<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Maternal Medicine | Essential Obstetrics and Gynaecology</title>
    
    <!-- Preconnect for performance -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    
    <!-- Google Fonts -->
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <!-- Main Stylesheet -->
    <link rel="stylesheet" href="../styles/main.css">
    
    <!-- MathJax Configuration -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams'
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <!-- Skip Link for Accessibility -->
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <!-- Reading Progress Bar -->
    <div class="reading-progress-container" aria-hidden="true">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <!-- Theme Toggle -->
    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode" title="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="page-wrapper">
        <!-- Floating Mini-TOC -->
        <aside class="floating-toc" id="floating-toc" aria-label="On this page">
            <div class="floating-toc-header">
                <span class="floating-toc-icon">üìë</span>
                <span>On this page</span>
            </div>
            <nav class="floating-toc-nav">
                <ul class="floating-toc-list">
                    <!-- Will be populated by JS -->
                </ul>
            </nav>
        </aside>

        <div class="container">
            <article class="document-article" role="main" id="main-content">
                <!-- Top Navigation -->
                <nav class="document-nav" role="navigation" aria-label="Document navigation">
                    <div class="nav-container">
                        <a href="../index.html" class="nav-button nav-button--toc" aria-label="Table of Contents">
                            <span class="nav-icon">üìö</span>
                            <span class="nav-text">Contents</span>
                        </a>
                        
                        <a href="chapter-08-obstetric-disorders.html" class="nav-button nav-button--prev" aria-label="Previous chapter">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Previous</span>
                        </a>
                        
                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span class="progress-current">09</span>
                                <span class="progress-separator">/</span>
                                <span class="progress-total">21</span>
                            </div>
                            <div class="progress-bar-container" aria-hidden="true">
                                <div class="progress-bar-fill" style="width: 43%;"></div>
                            </div>
                            <span class="progress-label">Maternal Medicine</span>
                        </div>
                        
                        <a href="chapter-10-fetal-wellbeing.html" class="nav-button nav-button--next" aria-label="Next chapter">
                            <span class="nav-text">Next</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                </nav>

                <!-- Breadcrumb -->
                <nav class="breadcrumb" aria-label="Breadcrumb">
                    <ol class="breadcrumb-list">
                        <li class="breadcrumb-item"><a href="../index.html">Home</a></li>
                        <li class="breadcrumb-item"><a href="#">Section 2: Essential Obstetrics</a></li>
                        <li class="breadcrumb-item active" aria-current="page">Chapter 9</li>
                    </ol>
                </nav>

                <!-- Document Header -->
                <header class="document-header">
                    <div class="header-badge">
                        <span class="badge-icon">üë©‚Äç‚öïÔ∏è</span>
                        <span class="badge-text">Chapter 9</span>
                    </div>
                    <h1 class="document-title">Maternal medicine</h1>
                    <p class="hero-subtitle">Suzanne V.F. Wallace, Henry G. Murray and David James</p>
                </header>

                <!-- Main Content Area -->
                <div class="content-wrapper">
                    
                    <!-- Learning Outcomes -->
                    <section id="learning-outcomes" class="content-section">
                        <div class="content-card">
                            <h2>Learning outcomes</h2>
                            <p>After studying this chapter you should be able to:</p>
                            
                            <h3>Knowledge criteria</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Describe the aetiology, risk factors for, risks and management of:
                                        <ul style="margin-top: 0.5rem; margin-bottom: 0;">
                                            <li>Anaemia in pregnancy</li>
                                            <li>Gestational diabetes</li>
                                            <li>Infections in pregnancy</li>
                                            <li>Thromboembolic disease in pregnancy</li>
                                            <li>Liver disease</li>
                                        </ul>
                                    </span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Contrast the clinical presentation and management of pre-existing medical conditions in pregnancy including:
                                        <ul style="margin-top: 0.5rem; margin-bottom: 0;">
                                            <li>Diabetes</li>
                                            <li>Obesity</li>
                                            <li>Thrombophilias</li>
                                            <li>Epilepsy</li>
                                            <li>Thyroid disease</li>
                                            <li>Cardiac disease</li>
                                            <li>Respiratory disease</li>
                                            <li>Renal disease</li>
                                            <li>Haemoglobinopathies</li>
                                        </ul>
                                    </span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Discuss the role of preconceptual counselling for women with pre-existing illness, and the risks and modifications required to continue drug treatment during pregnancy</span>
                                </li>
                            </ul>

                            <h3>Clinical competencies</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Explain to the mother the causes and plan the management of minor complaints of pregnancy including:
                                        <ul style="margin-top: 0.5rem; margin-bottom: 0;">
                                            <li>Abdominal pain</li>
                                            <li>Heartburn</li>
                                            <li>Constipation</li>
                                            <li>Backache</li>
                                            <li>Syncope</li>
                                            <li>Varicosties</li>
                                            <li>Carpal tunnel syndrome</li>
                                        </ul>
                                    </span>
                                </li>
                            </ul>
                        </div>
                    </section>

                    <!-- Introduction -->
                    <section id="introduction" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">01</div>
                            <h2 class="section-title">
                                <span class="title-icon">üè•</span>
                                INTRODUCTION
                            </h2>
                        </div>
                        
                        <div class="content-card">
                            <p>Maternal medicine encompasses the spectrum of medical conditions a woman can present with in pregnancy. Some of these may predate pregnancy and others may develop during pregnancy. Currently in the UK, with improvements in other areas of obstetric care, most maternal deaths are now caused by medical conditions. In the most recent edition of the Confidential Enquiry into Maternal Deaths (2006‚Äì2008) venous thromboembolism was responsible for maternal death in 0.79 per 100 000 maternities, whilst cardiac disease was responsible for maternal death in 2.31 per 100 000 maternities.</p>
                            <p>There are an increasing number of women with medical conditions in pregnancy. Women with significant preexisting medical conditions that in the past may have led to voluntary or involuntary infertility (for example, cystic fibrosis) are now becoming pregnant in increasing numbers. In addition, more women are older when embarking on pregnancy and have more acquired problems such as obesity and hypertension.</p>
                            <p>Whether a woman is known to have a medical condition prior to pregnancy or develops one within pregnancy, the key to successful management is to have a framework to ensure that all the implications of the condition are considered (Fig. 9.1). This enables robust pregnancy plans to be made whether a disease is common or rare. Multidisciplinary and multi-professional team-working are also essential elements in caring for these women.</p>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../../../../assets/images/image-20251213-4eeb7c60.jpeg" alt="Framework for medical disorders in pregnancy" class="figure-image" loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 9.1 Framework for medical disorders in pregnancy.</figcaption>
                            </figure>
                        </div>
                    </section>

                    <!-- Minor Complaints -->
                    <section id="minor-complaints" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">02</div>
                            <h2 class="section-title">
                                <span class="title-icon">üå°Ô∏è</span>
                                MINOR COMPLAINTS OF PREGNANCY
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Minor complaints of pregnancy by definition do not cause significant medical problems. However, minor medical complaints are often not perceived as minor by the women affected and can have considerable impact on a woman's quality of life in pregnancy. In addition, many of the symptoms of minor conditions of pregnancy are the same as those of significant pathological disease that needs to be excluded. Symptoms frequently relate to physiological adaptations of the body to pregnancy and women should be reassured (once pathology has been excluded) that these symptoms represent normal pregnancy changes.</p>

                            <h3>Abdominal pain</h3>
                            <p>Abdominal pain or discomfort is common in pregnancy and is usually transient. The physiological causes include:</p>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">stretching of the abdominal ligaments and muscles</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">pressure of the gravid uterus on the abdominal contents</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">constipation.</span>
                                </li>
                            </ul>
                            <p>It is important to differentiate physiological abdominal pain from pathological causes in women with severe, atypical or recurrent pain. These include:</p>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">early pregnancy problems such as ectopic pregnancy and miscarriage</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">gynaecological causes such as ovarian torsion</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">urinary tract infection</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">surgical causes such as appendicitis and pancreatitis</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">later obstetric causes such as placental abruption and labour.</span>
                                </li>
                            </ul>
                            <p>Social causes, particularly domestic abuse, should be considered in women who present with recurrent episodes of abdominal pain where organic pathology has been excluded.</p>
                            <p>Once a pathological cause has been excluded reassurance is often a successful management option and analgesics are rarely required.</p>

                            <h3>Heartburn</h3>
                            <p>Gastro-oesophageal reflux is more likely to occur in pregnancy because of delayed gastric emptying, reduced lower oesophageal sphincter pressure and raised intragastric pressure. It affects up to 80% of pregnant women, particularly in the third trimester. The differential diagnoses are:</p>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">other causes of chest pain such as angina, myocardial infarction and muscular pain</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">causes of upper abdominal pain that can mimic reflux, for example, pre-eclampsia, acute fatty liver of pregnancy and gallstones.</span>
                                </li>
                            </ul>
                            <p>Conservative management includes dietary advice to avoid spicy and acidic foods and to avoid eating just prior to bed. Symptoms can be improved by changing sleeping position to a more upright posture. If conservative measures are not successful antacids are safe in pregnancy and can be used at any time. Histamine-receptor blockers, such as ranitidine, and proton pump inhibitors have a good safety profile in pregnancy and can be used if antacids alone are insufficient to improve symptoms.</p>

                            <h3>Constipation</h3>
                            <p>Constipation is postulated to be more common in pregnancy because of both elevated progesterone levels slowing colonic motility and the pressure of the uterus on the rectum. It is particularly common in the first trimester. It can be exacerbated by oral iron supplements, frequently taken in pregnancy.</p>
                            <p>Women should be advised to increase their fluid and dietary fibre intake. Most laxatives are safe in pregnancy and can be considered if conservative management is unsuccessful. Rarely, severe constipation can be a cause of unstable lie in late pregnancy by preventing the fetal head from descending into the pelvis.</p>

                            <h3>Backache</h3>
                            <p>Backache is a very common pregnancy complaint especially as pregnancy advances. The commonest cause is a combination of pressure from the gravid uterus causing an exaggerated lumbar lordosis and a hormonal effect on the supporting soft tissues. Differential diagnoses include urinary tract infection, pyelonephritis and early labour.</p>
                            <p>Physiotherapy review can help by advising on posture and appropriate stretches and exercises. Simple analgesics may be required. Whilst paracetamol and codeine formulations are safe in pregnancy, aspirin and nonsteroidal anti-inflammatory medication should be avoided. One disadvantage of codeine is that it can cause constipation.</p>

                            <h3>Syncope</h3>
                            <p>Physiological vasodilatation from the effects of progesterone on the vascular smooth muscle causes a pooling of blood in dependent areas causing postural hypotension that can lead to syncope. Later in pregnancy, caval compression from the gravid uterus can occur (from around 20 weeks gestation), reducing further the venous return to the heart and precipitating hypotension. Whilst syncope in pregnancy is usually benign, if it is recurrent anaemia, hypoglycaemia, dehydration and arrhythmias should be excluded.</p>
                            <p>Women should be advised to sit for a while prior to standing when getting up from a lying position and to avoid prolonged standing; later in pregnancy lying supine should be avoided to reduce caval compression and supine hypotension. Dehydration should be avoided.</p>

                            <h3>Varicosities</h3>
                            <p>Varicosities in the legs or vulva may worsen or appear de novo because of a combination of pressure on the pelvic veins from the gravid uterus reducing venous return from lower limb veins and the progestogenic effect on relaxing the vascular smooth muscle. Their appearance is usually diagnostic, but if painful then thrombophlebitis and deep vein thrombosis should be excluded.</p>
                            <p>Elevating the legs while sitting or lying may improve symptoms. The use of compression stockings can both alleviate symptoms and reduce the risk of venous thromboembolism from stasis in the dilated veins. If severe varicosities are present and there are other risk factors for venous thromboembolism, heparin prophylaxis may need to be considered.</p>

                            <h3>Carpal tunnel syndrome</h3>
                            <p>Fluid retention occurs in pregnancy due to increased capillary permeability. This can cause or worsen carpal tunnel syndrome through compression of the median nerve as it travels through the carpal tunnel.</p>
                            <p>Wrist splints that reduce wrist flexion are usually the mainstay of treatment in the majority of cases. In severe cases steroid injections are occasionally required and can be given in pregnancy. Surgical release of the carpal tunnel ligament is rarely required with pregnancy-related carpal tunnel syndrome as most resolve post-pregnancy.</p>

                            <h3>Pelvic girdle dysfunction (symphyseal pelvic dysfunction, SPD)</h3>
                            <p>Raised levels of relaxin in pregnancy increase joint mobility to allow expansion of the pelvic ring for birth. However, in some women this effect can be exaggerated and cause discomfort either at the symphysis, the hip or at other points around the pelvis; this usually worsens with increasing gestation. Women often describe characteristic pain on walking or standing with tenderness over the pelvic ring. Urinary tract infection should be excluded with anterior pain.</p>
                            <p>Physiotherapists will advise on exercises to improve stability, techniques for minimizing symptoms during daily activities and positions for birth. A pelvic girdle support may improve symptoms. As with back pain, simple analgesics can be used. The problem usually resolves after pregnancy</p>
                        </div>
                    </section>

                    <!-- Medical Problems in Pregnancy -->
                    <section id="medical-problems" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">03</div>
                            <h2 class="section-title">
                                <span class="title-icon">ü©∫</span>
                                MEDICAL PROBLEMS ARISING IN PREGNANCY
                            </h2>
                        </div>

                        <!-- Anaemia -->
                        <div class="content-card">
                            <h3>Anaemia</h3>
                            <p>Anaemia commonly occurs in pregnancy. While in many developed countries it is mild and quickly and easily treated resulting in minimal complications, in some countries it is severe and a major contributor to maternal death.</p>

                            <h4>Aetiology</h4>
                            <p>Pregnancy causes many changes in the haematological system, including an increase in both plasma volume and red cell mass; the former is greater than the latter with the result that a 'physiological anaemia' often occurs. There is an increased iron and folate demand to facilitate both the increase in red cell mass and fetal requirements, which is not always met by maternal diet. Iron deficiency anaemia is thus a common condition encountered in pregnancy, particularly in the third trimester. Table 9.1 shows the changes of haemoglobin and red cell parameters in normal pregnancy.</p>

                            <div class="table-wrapper">
                                <div class="table-header">
                                    <span class="table-icon">üìä</span>
                                    <span class="table-caption">Table 9.1 Haemoglobin and red cell indices (mean and calculated 2.5th‚Äì97.5th percentile reference ranges)</span>
                                </div>
                                <div class="table-container">
                                    <table class="content-table">
                                        <thead>
                                            <tr>
                                                <th>Red cell indices</th>
                                                <th style="text-align: center;">18 weeks</th>
                                                <th style="text-align: center;">32 weeks</th>
                                                <th style="text-align: center;">39 weeks</th>
                                                <th style="text-align: center;">8 weeks postpartum</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td>Haemoglobin (Hb) g/dL</td>
                                                <td style="text-align: center;">11.9 (10.6‚Äì13.3)</td>
                                                <td style="text-align: center;">11.9 (10.4‚Äì13.5)</td>
                                                <td style="text-align: center;">12.5 (10.9‚Äì14.2)</td>
                                                <td style="text-align: center;">13.3 (11.9‚Äì14.8)</td>
                                            </tr>
                                            <tr>
                                                <td>Red cell count √ó 10¬π¬≤/L</td>
                                                <td style="text-align: center;">3.93 (3.43‚Äì4.49)</td>
                                                <td style="text-align: center;">3.86 (3.38‚Äì4.43)</td>
                                                <td style="text-align: center;">4.05 (3.54‚Äì4.64)</td>
                                                <td style="text-align: center;">4.44 (3.93‚Äì5.00)</td>
                                            </tr>
                                            <tr>
                                                <td>Mean cell volume (MCV) fL</td>
                                                <td style="text-align: center;">89 (83‚Äì96)</td>
                                                <td style="text-align: center;">91 (85‚Äì97)</td>
                                                <td style="text-align: center;">91 (84‚Äì98)</td>
                                                <td style="text-align: center;">88 (82‚Äì94)</td>
                                            </tr>
                                            <tr>
                                                <td>Mean cell haemoglobin (MCH) pg</td>
                                                <td style="text-align: center;">30 (27‚Äì33)</td>
                                                <td style="text-align: center;">30 (28‚Äì33)</td>
                                                <td style="text-align: center;">30 (28‚Äì33)</td>
                                                <td style="text-align: center;">30 (27‚Äì32)</td>
                                            </tr>
                                            <tr>
                                                <td>Mean cell haemoglobin concentration (MCH) g/dL</td>
                                                <td style="text-align: center;">34 (33‚Äì36)</td>
                                                <td style="text-align: center;">34 (33‚Äì36)</td>
                                                <td style="text-align: center;">34 (33‚Äì36)</td>
                                                <td style="text-align: center;">34 (33‚Äì36)</td>
                                            </tr>
                                            <tr>
                                                <td>Haematocrit</td>
                                                <td style="text-align: center;">0.35 (0.31‚Äì0.39)</td>
                                                <td style="text-align: center;">0.35 (0.31‚Äì0.40)</td>
                                                <td style="text-align: center;">0.37 (0.32‚Äì0.42)</td>
                                                <td style="text-align: center;">0.39 (0.35‚Äì0.44)</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>

                            <h4>Risk factors</h4>
                            <p>Pre-pregnancy risk factors are those associated with chronic anaemia:</p>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">iron deficiency secondary to poor diet</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">menorrhagia</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">short interval between pregnancies</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">presence of anaemic conditions, such as sickle cell disease, thalassaemia and haemolytic anaemia.</span>
                                </li>
                            </ul>
                            <p>Risk factors within pregnancy include multiple pregnancy due to the increased iron demand in multiple pregnancy scenarios.</p>

                            <h4>Clinical features and diagnosis</h4>
                            <p>Anaemia is often identified as the result of routine full blood count measurements. Some women will present with symptoms such as shortness of breath and lethargy. There is a variation in normal haemoglobin levels in pregnancy and a gradual fall as pregnancy progresses. Anaemia can be diagnosed with a haemoglobin level less than 11 g/dL in the first trimester and less than 10.5 g/dL in the second and third trimesters.</p>

                            <h4>Implications on pregnancy</h4>
                            <p>Iron-deficiency anaemia mainly affects the mother. With mild anaemia the fetus is usually unaffected despite the reduced oxygen-carrying capacity of the mother. However the baby is more likely to have iron deficiency in the first year of life because of a lack of development of fetal iron stores in utero. With severe anaemia there is an increased risk of preterm birth and low birth weight.</p>
                            <p>The implications to the mother in all trimesters are the risk of developing symptomatic anaemia that can cause fatigue, reduced work performance and an increase in susceptibility to infections. If anaemia persists to the time of delivery, there will be a lack of reserve if significant blood loss occurs. There is a strong association between severe anaemia and maternal mortality. The risk of requiring blood transfusions peripartum is also raised.</p>

                            <h4>Management</h4>
                            <p>Prompt recognition and treatment of developing anaemia optimizes a woman's haemoglobin levels in pregnancy and reduces the risk of commencing labour anaemic.</p>
                            <p>Although most anaemia in pregnancy is secondary to iron deficiency, consideration should be given as to whether there is an underlying anaemia condition or if folate deficiency could also be involved. If there is clinical suspicion that iron deficiency is not the cause of the anaemia or if a woman has failed to respond to iron supplementation then the iron status should be assessed by either ferritin or zinc protoporphyrin levels, folate measured and haemoglobin electrophoresis performed to exclude haemoglobinopathies. Oral iron supplementation is recommended as first line treatment. This is better absorbed if taken with ascorbic acid (for example, orange juice) and if tea and coffee are avoided at the time of ingestion. Dietary advice should also be given. Compliance with iron supplementation is often poor due to the side effects of constipation and gastric irritation. If iron is either not tolerated or if improvements in haemoglobin are not seen despite iron therapy then parenteral iron can be considered.</p>
                            <p>Adequate continued postnatal treatment is essential to reduce the risk of a woman entering a further pregnancy anaemic.</p>

                            <h4>Prophylaxis</h4>
                            <p>Routine iron supplementation throughout pregnancy may reduce the risk of iron deficiency. This is currently not a routine recommendation in the UK due to the lack of evidence of improved outcomes. In some other countries where iron deficiency is common, this is standard practice.</p>
                        </div>

                        <!-- Gestational Diabetes -->
                        <div class="content-card">
                            <h3>Gestational diabetes</h3>
                            <p>Gestational diabetes is an increasingly common antenatal condition occurring in 2‚Äì9% of all pregnancies.</p>

                            <h4>Aetiology</h4>
                            <p>Pregnancy induces a diabetogenic state. This is predominantly because of increased resistance to the actions of insulin due to the placental production of the anti-insulin hormones (human placental lactogen, glucagon and cortisol), though the increased production of maternal glucocorticoids and thyroid hormones during pregnancy also contribute to this. In response, the maternal pancreas must increase its production of insulin to combat this. In some women this is not achieved and gestational diabetes is the result.</p>

                            <h4>Risk factors</h4>
                            <p>Risk factors are the same as those for type 2 diabetes and are listed in Box 9.1. This list is taken from the NICE Clinical Guideline 'Diabetes in pregnancy' (2008). The Guideline only recommends that some of the risk factors should be used for screening in practice. The presence of one or more of these risk factors should lead to the offer of a 75 g oral glucose tolerance test (OGTT). However, many clinicians feel that the presence of any risk factor, rather than a subset, should trigger the offer of an OGTT.</p>

                            <aside class="callout callout--note">
                                <div class="callout-header">
                                    <span class="callout-icon">üìã</span>
                                    <span class="callout-title">Box 9.1 Women at increased risk of glucose intolerance in pregnancy</span>
                                </div>
                                <div class="callout-content">
                                    <ul class="enhanced-list">
                                        <li class="list-item">
                                            <span class="list-marker"></span>
                                            <span class="list-content"><strong>Previous large infant (more than 4.5 kg, or above the 95th centile for gestational age)*</strong></span>
                                        </li>
                                        <li class="list-item">
                                            <span class="list-marker"></span>
                                            <span class="list-content"><strong>Previous gestational diabetes*</strong></span>
                                        </li>
                                        <li class="list-item">
                                            <span class="list-marker"></span>
                                            <span class="list-content"><strong>First-degree relative with diabetes*</strong></span>
                                        </li>
                                        <li class="list-item">
                                            <span class="list-marker"></span>
                                            <span class="list-content"><strong>Obesity (BMI more than 30 kg/m¬≤)*</strong> or booking weight more than 100 kg</span>
                                        </li>
                                        <li class="list-item">
                                            <span class="list-marker"></span>
                                            <span class="list-content"><strong>Specific ethnic background:</strong>
                                                <ul style="margin-top: 0.5rem; margin-bottom: 0;">
                                                    <li>South Asian (specifically women whose country of family origin is India, Pakistan or Bangladesh)</li>
                                                    <li>Black Caribbean</li>
                                                    <li>Middle Eastern (specifically women whose country of family origin is Saudi Arabia, United Arab Emirates, Iraq, Jordan, Syria, Oman, Qatar, Kuwait, Lebanon or Egypt)</li>
                                                </ul>
                                            </span>
                                        </li>
                                        <li class="list-item">
                                            <span class="list-marker"></span>
                                            <span class="list-content">Macrosomia in current pregnancy</span>
                                        </li>
                                        <li class="list-item">
                                            <span class="list-marker"></span>
                                            <span class="list-content">Glycosuria ‚â• 1+ on more than one occasion or ‚â• 2+ on one occasion</span>
                                        </li>
                                        <li class="list-item">
                                            <span class="list-marker"></span>
                                            <span class="list-content">Previous unexpected perinatal death</span>
                                        </li>
                                        <li class="list-item">
                                            <span class="list-marker"></span>
                                            <span class="list-content">History of polycystic ovary syndrome</span>
                                        </li>
                                        <li class="list-item">
                                            <span class="list-marker"></span>
                                            <span class="list-content">Polyhydramnios</span>
                                        </li>
                                        <li class="list-item">
                                            <span class="list-marker"></span>
                                            <span class="list-content">FBG more than 6.0 mmol/L or random blood glucose more than 7.0 mmol/L</span>
                                        </li>
                                    </ul>
                                    <p><em>* Risk factors in bold are those that the NICE Clinical Guideline recommends should be used for screening in practice during pregnancy in the form of a 75 g oral glucose tolerance test.</em></p>
                                </div>
                            </aside>

                            <h4>Clinical features and diagnosis</h4>
                            <p>Gestational diabetes may be asymptomatic. As such, a screening programme needs to be in place that can either be universal or selective. Most units prefer a selective approach for practical and financial reasons. Selective screening is offered to the at-risk groups listed in Box 9.1. As described above, screening is by an 75 g OGTT at 28 weeks, or if very high risk, early in the second trimester and then repeated at 28 weeks (if normal at the first test). In the OGTT, a fasting glucose level is first measured, then a 75 g loading dose of glucose is given and a further glucose level taken at 2 hours post-sugar load. There is an ongoing debate as to the levels of glucose at which gestational diabetes should be diagnosed. Table 9.2 indicates the two most commonly used diagnostic criteria.</p>

                            <div class="table-wrapper">
                                <div class="table-header">
                                    <span class="table-icon">üìä</span>
                                    <span class="table-caption">Table 9.2 Diagnostic criteria for gestational diabetes using a 75 g oral glucose tolerance test</span>
                                </div>
                                <div class="table-container">
                                    <table class="content-table">
                                        <thead>
                                            <tr>
                                                <th>Diagnostic criteria</th>
                                                <th></th>
                                                <th style="text-align: center;">Normal fasting value (venous plasma glucose)</th>
                                                <th style="text-align: center;">Normal 2 hour value (venous plasma glucose)</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td>WHO 1999</td>
                                                <td>One or more abnormal values required</td>
                                                <td style="text-align: center;">&lt;7.0 mmol/L</td>
                                                <td style="text-align: center;">&lt;7.8 mmol/L</td>
                                            </tr>
                                            <tr>
                                                <td>IADPSG</td>
                                                <td>One or more abnormal values required</td>
                                                <td style="text-align: center;">&lt;5.1 mmol/L</td>
                                                <td style="text-align: center;">&lt;8.5 mmol/L</td>
                                            </tr>
                                            <tr>
                                                <td colspan="4" style="text-align: center; font-style: italic;">Comment: In a given population, use of the IADPSG criteria results in more diagnoses of 'gestational diabetes' than using the WHO criteria.</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>

                            <h4>Implications on pregnancy</h4>
                            <p>Gestational diabetes is predominantly a disease of the third and sometimes second trimester (Table 9.3). In the mother, the presence of gestational diabetes increases the risk of recurrent infections and of pre-eclampsia developing. For the fetus there is increased risk of polyhydramnios and macrosomia, the latter being related to the degree of glucose control. There is an increased risk of stillbirth. Considering birth, women with gestational diabetes are more likely to have an induction of labour. If vaginal birth occurs, shoulder dystocia, an instrumental birth and extended perineal tears are more common. Women with diabetes are more likely to have a caesarean section. Babies are more likely to need admission to the neonatal unit. They are at increased risk of neonatal hypoglycaemia due to the relative over-activity of the fetal pancreas in utero. This is less likely to occur if maternal blood sugars are well controlled around the time of birth. Maternal glucose readily crosses the placenta whilst insulin does not.</p>

                            <div class="table-wrapper">
                                <div class="table-header">
                                    <span class="table-icon">üìä</span>
                                    <span class="table-caption">Table 9.3 Effect of gestational diabetes on pregnancy</span>
                                </div>
                                <div class="table-container">
                                    <table class="content-table">
                                        <thead>
                                            <tr>
                                                <th></th>
                                                <th>Maternal risks/complications</th>
                                                <th>Fetal/neonatal risks/complications</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td>First trimester</td>
                                                <td>-</td>
                                                <td>-</td>
                                            </tr>
                                            <tr>
                                                <td>Second trimester / Third trimester</td>
                                                <td>Pre-eclampsia<br>Recurrent infections</td>
                                                <td>Macrosomia<br>Polyhydramnios<br>Stillbirth</td>
                                            </tr>
                                            <tr>
                                                <td>Labour</td>
                                                <td>Induction of labour<br>Poor progress in labour</td>
                                                <td></td>
                                            </tr>
                                            <tr>
                                                <td>Delivery</td>
                                                <td>Instrumental birth<br>Traumatic delivery<br>Caesarean section</td>
                                                <td>Shoulder dystocia</td>
                                            </tr>
                                            <tr>
                                                <td>Postnatal</td>
                                                <td></td>
                                                <td>Neonatal hypoglycaemia<br>Neonatal unit admission<br>Respiratory distress syndrome<br>Jaundice</td>
                                            </tr>
                                            <tr>
                                                <td>Longer term</td>
                                                <td>Type 2 diabetes later in life</td>
                                                <td>Obesity and diabetes in childhood and later life</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>

                            <p>Whilst for the majority of women gestational diabetes will resolve post-pregnancy, in some women this diagnosis is the unmasking of type 2 diabetes and diabetic care will need to continue. Women who have had gestational diabetes remain at higher risk of developing type 2 diabetes later in life. For the babies, fetal programming effects increase the risk of obesity and diabetes in later childhood.</p>

                            <h4>Management</h4>
                            <p>Multi-disciplinary teams consisting of obstetricians, diabetic physicians, diabetic specialist nurses and midwives and dieticians should manage diabetes in pregnancy.</p>
                            <p>Antenatally, the aim is to reduce the risk of complications by achieving good glucose control. Initially, this is by dietary measures aiming to avoid large fluctuations in glucose levels: consuming increased amounts of low glycaemic index carbohydrate and lean protein and avoiding high glycaemic index carbohydrate foods. If this is unsuccessful then medication can be used. Metformin and glibenclamide are increasingly used in pregnancy and may reduce the need for insulin, but a number of women with gestational diabetes will need insulin to optimize control. The aim is that preprandial/fasting capillary glucose levels should be between 4.0 and 6.0 mmol/L and that 2-hour post-prandial value should be between 6.0 and 8.0 mmol/L. Randomized-controlled trial evidence has demonstrated that treatment of gestational diabetes with the aim of achieving normoglycaemia in the woman improves outcomes. Serial growth scans are advised to alert to increasing macrosomia.</p>
                            <p>Delivery at term is recommended to reduce the risk of stillbirth. This may need to be brought forward depending on the degree of diabetic control, the presence of macrosomia or if other conditions have arisen, such as preeclampsia. In labour, blood glucose should be regularly measured and hyperglycaemia treated to reduce the risk of neonatal hypoglycaemia. The fetus should be continuously monitored. Diabetic therapy can be discontinued with the delivery of the placenta. The baby will need blood glucose measurements to look for hypoglycaemia, and feeding should be commenced early to assist the baby in maintaining its sugar level.</p>
                            <p>Postnatally, all diabetic treatment should be discontinued and capillary glucose testing continued. In the majority of women these values will be normal, indicating that this was genuine gestational diabetes. If they remain elevated then there is a suspicion of type 2 diabetes and referral to a diabetic team is indicated. Women should be advised of the long-term implications of gestational diabetes and the need for regular screening by, for example, an annual OGTT by their general practitioner. Advice on reducing other lifestyle risks associated with diabetes may also be appropriate.</p>
                        </div>

                        <!-- Infections Acquired in Pregnancy -->
                        <div class="content-card">
                            <h3>Infections acquired in pregnancy</h3>
                            <p>Women will encounter infections in pregnancy just as they would outside of pregnancy. However, the relative immunosuppressive conditions of pregnancy can affect the way the body responds to the infection.</p>

                            <h4>Risk factors</h4>
                            <p>Pregnant women with small children or who work with children are more likely to come across many infectious conditions.</p>

                            <h4>Implications on pregnancy and management</h4>
                            <p>The implications on pregnancy and management vary depending on the specific infection. Once more, it is vital to consider both the impact on the mother and the fetus. The impact on the fetus can change when the same infection is contracted at different gestations.</p>

                            <h4>Chicken pox</h4>
                            <p>Chicken pox is a highly infectious childhood illness caused by Varicella zoster virus; it has significant implications on both the mother and fetus. Pregnant women are particularly at risk of developing a varicella pneumonia that has a high maternal and fetal mortality rate. If acquired early in pregnancy, there is a 1‚Äì2% risk to the fetus of congenital varicella syndrome (eye defects, limb hypoplasia and neurological abnormalities). If acquired near term there is a risk of neonatal varicella that has a significant mortality risk.</p>
                            <p>If a non-immune pregnant woman is exposed to chicken pox, she can be offered zoster immunoglobulin to reduce the risk of infection. If a woman becomes infected, aciclovir should be given to reduce the risk of maternal complications. Ultrasound imaging can screen for congenital varicella syndrome. With infection at term, delivery should ideally be delayed to allow time for passive transfer of antibodies to the fetus. Care should be taken to avoid contact with other non-immune pregnant women.</p>

                            <h4>Parvovirus B19</h4>
                            <p>Infection with parvovirus B19 is also known as erythema infectiosum, fifth disease or 'slapped cheek syndrome'. A common childhood illness, maternal symptoms can include fever, rash and arthropathy, but often effects are minimal. In contrast, there are potentially significant fetal effects as parvovirus infects rapidly dividing cells and can cause miscarriage in early pregnancy and fetal anaemia and heart failure ('fetal hydrops') later in pregnancy.</p>
                            <p>Management includes the use of simple analgesics and antipyretic agents for the maternal symptoms and avoidance of contact with other pregnant women. If the infection is contracted after 20 weeks, serial Doppler ultrasound scanning of the blood flow in the fetal middle cerebral artery can detect fetal anaemia (blood flow increased) that may need to be treated with in utero blood transfusions.</p>

                            <h4>Influenza H1N1</h4>
                            <p>Influenza H1N1 caused world-wide pandemic infection in 2009 and 2010 and is now one of the predominant seasonal influenza virus strains. Pregnant women present with fever and cough similar to non-pregnant individuals. However, pregnant women are at greater risks of complications such as respiratory failure and secondary bacterial infections and have a significantly higher risk of dying than non-pregnant individuals. In addition, implications include an increased risk of preterm birth, stillbirth and neonatal death.</p>
                            <p>Management includes treatment with antiviral agents, such as oseltamivir or zanamivir, and respiratory support if necessary. All pregnant women should be advised to be immunized against H1N1.</p>

                            <h4>Human Immunodeficiency Virus (HIV) Infection</h4>
                            <p>HIV is a virus that weakens the immune system and over time AIDS (acquired immune deficiency syndrome) may develop. HIV also increases the risk of catching other infections and developing cancers. However, people with HIV infection may be asymptomatic for many years. The number of people living with HIV worldwide is increasing and a significant proportion of these are women of reproductive age. With advancing disease, highly active antiretroviral therapy (HAART) has been shown to reduce morbidity and mortality from HIV infection.</p>
                            <p><strong>Implications of pregnancy on the disease:</strong> Pregnancy does not appear to accelerate the course of HIV infection or increase the chance of AIDS developing.</p>
                            <p><strong>Implications of the disease on pregnancy:</strong> The main concern in pregnancy is the high risk of vertical transmission (up to 45%) of HIV from mother to baby without medical intervention. This can occur transplacentally in the antenatal period, during vaginal birth and postnatally through breastfeeding. The risk is highest in advanced disease, at seroconversion and with high viral loads. In women who do not breastfeed, transmission rates fall to less than 25%. With medical intervention in the form of multiple anti-retroviral therapy it is possible to reduce vertical transmission further to less than 2%.</p>
                            <p>In addition there are increased risks of miscarriage, fetal growth restriction, prematurity and stillbirth in women with advanced HIV disease.</p>
                            <p>Some women will already be on HAART prior to pregnancy and this should be reviewed to consider the safety of individual medications in pregnancy. Many women will be treatment na√Øve.</p>
                            <p>Women who are taking HAART and have viral loads less than 400 copies /mL can deliver vaginally as there is a very low risk of vertical transmission. However, those who are not taking HAART and/or have viral loads of ‚â• 400 copies /mL or more should be advised to have a caesarean section to reduce the risk of vertical transmission.</p>
                            <p><strong>Screening:</strong> Although many women will know they have HIV when they become pregnant, some women will be unaware that they are HIV positive due to the long asymptomatic stage of the condition. In view of this, the high vertical transmission rate and the efficacy of intervention, many countries now advocate screening in pregnancy. This is usually performed early in pregnancy but in high-risk women it may be appropriate to offer repeat testing later in pregnancy. Women should be fully counselled about the reason for screening for HIV and the improvements in outcome that can be achieved if HIV is diagnosed.</p>
                            <p><strong>Management:</strong> Women with HIV who become pregnant should be managed jointly by a specialist obstetrician and HIV physician. Input from the paediatric team should occur antenatally to discuss neonatal screening and treatment.</p>
                            <p>Women should be regularly assessed clinically and with blood measurements of viral load and CD4 count.</p>
                            <p>The initial package of care for women with HIV in pregnancy involves anti-HIV medication, caesarean section and avoiding breastfeeding. The use of anti-HIV drugs in pregnancy has been shown to reduce the risk of vertical transmission. Some women will already be taking HAART for their own health needs and this should continue. In treatment na√Øve women, anti-HIV medication should commence in the second trimester and continue until birth. Regimes used include zidovudine monotherapy and HAART (nucleotide analogues and protease inhibitors appear relatively safe, non-nucleoside reverse transcriptase inhibitors should be avoided). However, HAART is the recommended treatment of choice. Whilst caesarean section is still advocated for women with non-suppressed disease, women with a viral load of &lt;400 copies /ml who have taken HAART in pregnancy can now opt for vaginal birth without increasing transmission. Invasive procedures should be avoided in pregnancy and labour, for example amniocentesis, the use of fetal scalp electrodes and fetal scalp blood sampling.</p>
                            <p>Neonatal screening for HIV infection commences at birth and continues until 12 weeks. Babies require neonatal antiretroviral treatment as postexposure prophylaxis for several weeks. Women should be strongly advised not to breastfeed.</p>
                            <p>Confidentiality is an issue for some women with HIV whose families may not know their status. Women should be reassured that confidentiality can and will be maintained despite the increased medical intervention.</p>

                            <h4>Acute viral hepatitis</h4>
                            <p>Seven hepatitis viruses have been identified, the most common being hepatitis A, B and C. All can present similarly with general malaise, nausea, vomiting and pyrexia together with hepatic dysfunction; however with hepatitis B and C a significant proportion can be asymptomatic (up to 80% of women with hepatitis C). Hepatitis A is spread by the faeco-oral route while B and C are transmitted by a blood-borne route. They can be differentiated by serological tests. Hepatitis A is usually cleared after the initial infection, hepatitis B can be cleared, can persist as a carrier state or can lead to chronic infection, and hepatitis C commonly leads to chronic infection and a long-term risk of cirrhosis and liver failure.</p>
                            <p>The incidence of hepatitis in pregnancy has a wide geographical variation. In the UK, 1‚Äì4% of women will be infected with hepatitis B or C.</p>
                            <p>Pregnancy does not usually change the course of an acute hepatitis infection. A small number of chronic hepatitis B carriers may suffer a reactivation of the disease state during pregnancy. There is some evidence that pregnancy in women with hepatitis C may cause acceleration of the disease progression.</p>
                            <p>Hepatitis usually does not impact on the pregnancy itself. In women who have a severe acute infection during pregnancy, there is an increase in the incidence of spontaneous preterm labour. The main concern is the risk of transmission to the neonate. With hepatitis A this can happen if acute infection occurs in the last couple of weeks before delivery. With chronic hepatitis B and C, carriage transmission can occur perinatally. In women with chronic hepatitis C, vertical transmission will occur in 1 in 20 births.</p>
                            <p>Management in pregnancy relates to prevention, identification and reduction of the risk of vertical transmission. The risk of hepatitis A infection can be reduced by hygiene measures and consideration of immunization for women in areas of endemic hepatitis A infection. Women at risk of hepatitis B and C should be counseled regarding risktaking behaviour (particularly, intravenous drug use). Hepatitis B immunization can be offered before pregnancy, however there is currently no effective immunization against hepatitis C.</p>
                            <p>Women can be screened for hepatitis B and C in pregnancy. This may be universal or selective screening based on a woman's history. Identification antenatally is important to reduce vertical transmission. In women with hepatits C, co-infection with HIV should be excluded.</p>
                            <p>Vertical transmission of hepatitis B and C is not reduced by either caesarean delivery or avoidance of breast-feeding. Thus vaginal delivery is advocated (unless there are other obstetric indications for caesarean delivery), but with avoidance of interventions that may increase blood contact, such as fetal scalp electrode siting or fetal blood samples. Babies of mothers with hepatitis B can be treated with hepatitis B immunoglobulin and early hepatitis B immunization, which reduces transmission rates to 5‚Äì10%. There are limited options to reduce transmission rates with hepatitis C, but early identification of infected neonates ensures adequate follow up for the risk of chronic liver disease.</p>

                            <h4>Tuberculosis</h4>
                            <p>Tuberculosis remains a world health issue with at least 8 million new cases per year and up to 2 million deaths. Although the developed world has low rates of infection, higher rates are found in refugees and travelers to and from endemic areas. The two main risks to the fetus are the use of certain anti-tuberculous drugs and if the mother has severe respiratory illness with sustained hypoxia. Mycobacterium tuberculosis rarely crosses the placenta. The risks to the woman from untreated TB are the same as in non-pregnant patients. Tuberculin testing should be undertaken if the disease is suspected. Chest X-ray and sputum culture should be performed in those who test positive. If the diagnosis is confirmed then multiple therapy, as in the non-pregnant patient, is indicated.</p>
                            <p>Streptomycin is the only drug that is absolutely contraindicated in pregnancy because of the risk of fetal ototoxicity.</p>

                            <h4>Malaria</h4>
                            <p>Malaria occurs in over 200 million people per year and results in more than 1 million deaths annually. It is a common complication of pregnancy in those countries where the disease is endemic. Women who live in endemic areas show an increased prevalence of the severe forms of the disease. The severity of disease is related to the species of parasite, the level of parasitaemia and the immune status of the individual. Plasmodium falciparum is the most virulent of the organisms, as it attacks all forms of the erythrocyte. The parasite grows in the placenta and placental malaria occurs in anywhere between 15 and 60% of cases. Congenital malaria is rare in the infants born to mothers who have immunity as protective immunoglobulin G crosses the placenta.</p>
                            <p>The main risk of acute malaria to the woman is severe anaemia and its consequences. In the fetus, acute malaria is associated with an increased likelihood of growth restriction, miscarriage, preterm birth, congenital infection and perinatal death.</p>
                            <p>Mothers travelling to endemic areas should take prophylaxis or, preferably, not go to the area until the pregnancy is completed. They should also be advised to keep their skin covered and to use insecticides to minimize the risk of being bitten by mosquitoes.</p>
                            <p>Drug treatment of an acute attack will depend on the nature of the infection. Prophylaxis is given in the form of chloroquine phosphate at a dose of 300 mg each week, starting 1 week before travel and continuing for 4 weeks after leaving the area. Where chloroquine-resistant strains exist, a combination of chloroquine and pyrimethamine with sulfadoxine can be used, or proguanil and mefloquine. These drugs need to be taken with a folic acid supplement. Although chloroquine can cause retinal and cochleovestibular damage in high doses in both the mother and the fetus, it has never been shown to be associated with an increased incidence of birth defects where it has been taken for prophylaxis.</p>

                            <h4>Acute pyelonephritis and urinary tract infections</h4>
                            <p>Asymptomatic bacteriuria occurs in 2‚Äì10% of all sexually active women. When pregnant, 12‚Äì30% of this group of women will develop pyelonephritis from ascending infection due to structural and immune changes to the renal tract. If the bacteriuria is treated with antibiotics, the risk of later development of acute ascending urinary tract infection can be minimized. Nevertheless, approximately 1% of all pregnancies are complicated by an episode of acute pyelonephritis. The common organism is Escherichia coli and this should be treated aggressively with antibiotics according to known sensitivity. Most community-acquired infections are usually sensitive to amoxicillin or cefuroxime. Additional treatment with fluid replacement, pain relief and bed rest may also be of benefit. Pyelonephritis in pregnancy must not be underestimated as over 15% of women will develop a bacteraemia, with a small proportion of these progressing to septic shock and/or preterm labour.</p>
                        </div>

                        <!-- Thromboembolic Disease -->
                        <div class="content-card">
                            <h3>Thromboembolic disease</h3>
                            <p>Venous thromboembolism (VTE) is one of the leading causes of maternal mortality in the developed world. VTE is around 10 times more common in pregnancy than when not pregnant.</p>

                            <h4>Aetiology</h4>
                            <p>Pregnancy is a prothrombotic state. Coagulation factors increase, endogenous anticoagulants decrease and fibrinolysis is suppressed. These effects commence in the first trimester and last until a few weeks following birth. In addition venous stasis occurs in the lower limbs from compression on the pelvic vessels further exacerbating the problem.</p>

                            <h4>Risk factors</h4>
                            <p>Risk factors can predate pregnancy, occur as a result of obstetric conditions or can be transient. They include:</p>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">pre-existing risk factors:
                                        <ul style="margin-top: 0.5rem; margin-bottom: 0;">
                                            <li>a personal or family history of VTE</li>
                                            <li>thrombophilias, obesity, cigarette smoking, some medical conditions (such as sickle cell disease), gross varicose veins and increased maternal age</li>
                                        </ul>
                                    </span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">transient risk factors:
                                        <ul style="margin-top: 0.5rem; margin-bottom: 0;">
                                            <li>episodes of immobility and dehydration</li>
                                            <li>ovarian hyperstimulation</li>
                                            <li>surgical procedures</li>
                                        </ul>
                                    </span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">obstetric risk factors:
                                        <ul style="margin-top: 0.5rem; margin-bottom: 0;">
                                            <li>multiple pregnancy</li>
                                            <li>pre-eclampsia</li>
                                            <li>operative delivery.</li>
                                        </ul>
                                    </span>
                                </li>
                            </ul>

                            <h4>Clinical features and diagnosis</h4>
                            <p>VTE presents as in non-pregnant individuals: deep vein thrombosis (DVT) with swelling and tenderness of a leg and pulmonary embolism (PE) with respiratory symptoms (shortness of breath and pleuritic chest pain) or collapse. In pregnancy, DVT is more likely to occur on the left (90%) due to compression of the left common iliac vein by the right common iliac artery and ovarian artery (the vein is not crossed on the right). The majority of DVTs in pregnancy occur in the ileofemoral veins, so lower limb symptoms may not be as obvious. Clots in the ileofemoral veins are more likely to embolise than those in the calf.</p>
                            <p>D-Dimer measurements are of limited help in pregnancy, although the negative predictive value is high, a positive result does not help to establish a diagnosis as it can increase with the physiological changes in the coagulation system that occur in pregnancy.</p>
                            <p>Radiological investigations should be performed as in non-pregnant individuals. Doppler ultrasound of the lower limb veins or MRI of the pelvic veins should be performed to assess for DVT. Spiral artery CT or venous perfusion scanning are used to diagnose PE. Although care must be taken when undertaking radiological examinations in pregnancy because of the radiation risk to the fetus, ultimately if an investigation needs to be done to establish a diagnosis it should be done.</p>

                            <h4>Implications on pregnancy</h4>
                            <p>Antenatally, if VTE is adequately treated there are minimal direct effects to mother or fetus. The main implications to pregnancy relate to the medications used to treat VTE (see below). Postnatally, the risk remains high and therapy will need to continue for a number of weeks.</p>

                            <h4>Management</h4>
                            <p>All women should have an individual risk assessment undertaken for VTE in pregnancy. Depending on the risk score, a plan for thromboprophylaxis can be made to reduce the risk of thrombosis occurring. For women with low risk this may not require additional measures; for some women postnatal prophylaxis may be required and for those at highest risk antenatal prophylaxis may be recommended with graduated elastic compression stockings and low molecular weight heparin (LMWH). In this last scenario, thromboprophylaxis should be started as early as possible in pregnancy.</p>
                            <p>If acute VTE occurs in pregnancy, prompt management is vital and heparin therapy should be commenced empirically whilst awaiting investigations. If a DVT or PE are excluded on subsequent diagnostic testing (see above) then the heparin can be discontinued.</p>
                            <p>LMWH has been used extensively in pregnancy as it does not cross the placenta and has a good safety profile. In contrast, warfarin crosses the placenta and is associated with an embryopathy if used in the first trimester and with fetal intracranial bleeding when used in the third trimester. Most women with venous thromboembolism can be adequately managed on LMWH so warfarin is rarely needed in this scenario. On most occasions heparin therapy can be temporarily stopped around the time of birth to reduce the risk of postpartum haemorrhage and to enable regional anaesthesia to be given if required (LMWH use is associated with epidural haematoma). Simple measures such as avoiding dehydration and using graduated elastic compression stockings should also be employed.</p>
                            <p>Postnatally, women traditionally continue on heparin prophylaxis or treatment for 6 weeks. If an acute venous thromboembolic event has occurred in this pregnancy it is likely that heparin prophylaxis will be needed in future pregnancies. Women should also be advised to avoid oestrogen-containing contraceptives.</p>
                        </div>

                        <!-- Liver Disease -->
                        <div class="content-card">
                            <h3>Liver disease</h3>
                            
                            <h4>Obstetric cholestasis</h4>
                            <p><strong>Aetiology:</strong> The exact aetiology of obstetric cholestasis is uncertain; however, there appears to be a genetic predisposition to sensitivity to oestrogen which causes abnormalities in liver function.</p>
                            <p><strong>Risk factors:</strong> Certain ethnicities (South American and South Asian) and a past history of obstetric cholestasis are the predominant risk factors for obstetric cholestasis.</p>
                            <p><strong>Clinical features and diagnosis:</strong> Obstetric cholestasis presents with intense itching, especially on the palms of the hands and soles of the feet in the second or third trimester. There is rarely a rash associated with the itching, but excoriation marks are frequently present. Rarely, pale stools, dark urine and jaundice are noted. The diagnosis is confirmed by a rise in bile acids or raised liver transaminases where other pathology (autoimmune disease, gallstones and viral infection) has been excluded. Some women experience similar symptoms when taking the combined oral contraceptive pill or in the second half of the menstrual cycle.</p>
                            <p><strong>Implications on pregnancy:</strong> Antenatally, the pruritus can be debilitating giving minimal rest, especially at night. The impact on other liver functions can result in a prolongation of blood clotting time. For the fetus there is a small increase in the risk of stillbirth. The risk of preterm birth is higher but this is predominantly due to early induction of labour. The implications for labour and delivery are minimal, but meconium is more likely to be passed in preterm fetuses with obstetric cholestasis. Obstetric cholestasis has a high recurrence rate (over 90%) in future pregnancies.</p>
                            <p><strong>Management:</strong> The pruritus of obstetric cholestasis can be difficult to treat. Topical emollients are safe for use in pregnancy but provide little symptomatic relief. Antihistamines are sometimes used for their sedative ability but have little impact on the itch itself. Ursodeoxycholic acid has been shown to improve both pruritus and liver function, but long-term safety data is lacking. In spite of this it is the mainstay of antenatal treatment. In view of the potential risk of clotting abnormalities, oral water-soluble vitamin K supplementation can be used, particularly for those women whose clotting tests suggest an abnormality.</p>
                            <p>The best way to monitor the fetus antenatally has not yet been established. Methods such as serial growth scans and cardiotocographs (CTGs) that can detect problems with placental function are not predictive of at-risk fetuses in obstetric cholestasis. Consequently delivery once fetal maturation is reached is often recommended to reduce the small risk of late stillbirth.</p>
                            <p>Postnatally, women are usually advised to avoid oestrogen-containing contraceptives which can precipitate further symptoms.</p>

                            <h4>Acute fatty liver of pregnancy</h4>
                            <p><strong>Aetiology:</strong> Acute fatty liver of pregnancy (AFLP) is a rare but serious condition of pregnancy. The aetiology is uncertain but it shares many characteristics with severe pre-eclampsia and HELLP syndrome (haemolysis, raised liver enzymes and a low platelet count) and is postulated to be a variant of pre-eclampsia.</p>
                            <p><strong>Risk factors:</strong> First pregnancy, multiple pregnancy and obesity are all risk factors.</p>
                            <p><strong>Clinical features and diagnosis:</strong> AFLP usually presents in the third trimester with nonspecific symptoms of nausea, vomiting, abdominal pain and general malaise. Jaundice may also be present and women can rapidly deteriorate with liver failure, renal impairment and coagulopathy. Liver and renal function tests are usually deranged and hypoglycaemia may be present.</p>
                            <p><strong>Implications on pregnancy:</strong> The condition is associated with high maternal and fetal mortality. Maternal death occurs secondary to hepatic encephalopathy, haemorrhage and disseminated intravascular coagulation.</p>
                            <p><strong>Management:</strong> Management must be multi-disciplinary with support from critical care professionals. Initial management is supportive to correct the abnormalities present. Once the woman is stable, delivery should be expedited. Dialysis may be necessary postnatally; rarely, liver transplantation is required. Information regarding recurrence rates is sparse given the rarity of the condition, but is suggestive of an increased chance of recurrence.</p>
                        </div>
                    </section>

                    <!-- Pre-existing Medical Conditions -->
                    <section id="pre-existing-conditions" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">04</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß¨</span>
                                PRE-EXISTING MEDICAL CONDITIONS AND PREGNANCY
                            </h2>
                        </div>
                        
                        <div class="content-card">
                            <p>An increasing number of women are now entering pregnancy with pre-existing medical conditions. Ideally these women should be offered preconceptual counselling to allow the implications of pregnancy with their specific medical condition to be discussed and a plan put in place. This may involve deferring pregnancy until a specific target in the disease management is met. However, this opportunity is frequently missed.</p>

                            <h3>Renal disease in pregnancy</h3>
                            <p>Pregnancies complicated by chronic renal disease are rare (0.15%), however they are associated with a significant risk of adverse maternal and fetal outcomes. In the majority of cases, the risks and management relate to the degree of renal impairment and not to the underlying cause of the renal disease.</p>

                            <h4>Implications of pregnancy on the disease</h4>
                            <p>In women with chronic renal disease, pregnancy can cause a deterioration of renal function. Mostly this will recover after the end of the pregnancy, but for some women this will lead to a permanent reduction in renal functioning and a shorter time to end stage renal failure. The likelihood of renal deterioration depends on baseline creatinine as shown in Table 9.4.</p>

                            <div class="table-wrapper">
                                <div class="table-header">
                                    <span class="table-icon">üìä</span>
                                    <span class="table-caption">Table 9.4 Maternal renal function and chronic renal disease in pregnancy</span>
                                </div>
                                <div class="table-container">
                                    <table class="content-table">
                                        <thead>
                                            <tr>
                                                <th></th>
                                                <th>Serum creatinine (mmol/L)</th>
                                                <th>Loss of >25% renal function in pregnancy (%)</th>
                                                <th>Deterioration of renal function post-partum (%)</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td>Mild renal impairment</td>
                                                <td>&lt;125</td>
                                                <td>2</td>
                                                <td>0</td>
                                            </tr>
                                            <tr>
                                                <td>Moderate renal impairment</td>
                                                <td>124‚Äì168</td>
                                                <td>40</td>
                                                <td>20</td>
                                            </tr>
                                            <tr>
                                                <td>Severe renal impairment</td>
                                                <td>&gt;177</td>
                                                <td>70</td>
                                                <td>50</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>

                            <h4>Implications of the disease on pregnancy</h4>
                            <p>Renal disease is associated with increased risks of pre-eclampsia, growth restriction, preterm birth and a caesarean birth. The risks of an adverse outcome are related to the degree of renal impairment, the presence of hypertension and the presence of proteinuria. Most women with mild renal impairment will have good outcomes.</p>

                            <h4>Management</h4>
                            <p>Women with chronic renal disease should ideally be seen for pre-pregnancy counseling to discuss the implications of a potential pregnancy so that informed decisions can be made. For some women the risk of deterioration to end stage renal failure and a requirement for dialysis will be too great.</p>
                            <p>Pregnant women with renal disease should be offered care in multidisciplinary clinics that include an obstetrician and a renal or obstetric physician. Initial review should involve assessment of baseline renal function, blood pressure and proteinuria. Low dose aspirin (75 mg) from 12 weeks until delivery should be offered to reduce the risk of pre-eclampsia. Women already on antihypertensive treatment may need their medications reviewed to ensure that they are appropriate for pregnancy. Careful surveillance of blood pressure, renal function and for urinary tract infection is required throughout pregnancy. Growth scans should be arranged in the third trimester to assess fetal growth. For women with proteinuria, prophylactic heparin may be required to reduce the risk of venous thromboembolism. All women are at increased risk of urinary tract infections, women with chronic renal disease and the presence of more than one confirmed urinary tract infection may benefit from the use of prophylactic antibiotics.</p>

                            <h4>Special circumstances</h4>
                            <p>In addition to the general considerations, some renal conditions need additional plans. For example, polycystic kidney disease is an autosomal dominant condition, so women affected by this condition should be counseled about the inheritance risk to their baby.</p>
                            <p>Women with renal transplants generally do very well in pregnancy. Conception should be avoided in the immediate post-transplant period when risks of rejection are highest and anti-rejection medications are being stabilized. Many immunosuppressive drugs are safe for use in pregnancy, but pre-pregnancy counseling is important to allow time for change in medications in those cases where teratogenicity is a risk.</p>

                            <h4>Renal calculi</h4>
                            <p>Symptomatic renal stone disease is no more common in pregnancy than in the non-pregnant state. However, women with renal calculi have an increased frequency of urinary tract infections and such infections should be treated for longer than isolated urinary tract infections in women without renal stones. Fluid loading, alkalinization of the urine and pain relief with conservative management should be the first line of management, as this will tend to prevent the precipitation of uric acid and cystine stones. In the absence of comprehensive data concerning safety, lithotripsy should be avoided in pregnancy.</p>

                            <h3>Diabetes mellitus</h3>
                            <p>Diabetes is one of the commonest pre-existing medical conditions women are seen with in pregnancy. The incidence of pregnant women with pre-existing diabetes is around 0.4%. The majority of these have type 1 diabetes; however, with changes in population demographics there are an increasing number of women with type 2 diabetes.</p>
                            <p>Women with type 2 diabetes tend to be older, be more obese and have more unplanned pregnancies than women with type 1 diabetes. Rates of complications in pregnancy are similar in both groups of women.</p>

                            <h4>Implications of pregnancy on the disease</h4>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">The anti-insulin effects of placental hormones (see gestational diabetes, above) result in a larger insulin requirement in pregnancy. Women have to increase their insulin requirements up to threefold to combat this. These changes revert to the prepregnancy state within hours of birth.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Vomiting in early pregnancy can complicate diet and medication balance.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Pregnancy can reduce the 'warning signs' of hypoglycaemia.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">In women with complications of diabetes, such as retinopathy and nephropathy, pregnancy can accelerate the progress of these complications.</span>
                                </li>
                            </ul>

                            <h4>Implications of the disease on pregnancy</h4>
                            <p>Many of the complications seen with gestational diabetes are also seen with women with pre-existing diabetes. However, there are additional complications related to abnormal glucose homeostasis in the periconception period and in the first trimester, as well as complications related to long-standing underlying vascular disease.</p>
                            <p>There is an increased risk of congenital abnormality in women with pre-existing diabetes, particularly neural tube defects and congenital heart disease; the likelihood of this occurring is related to the level of glycaemic control periconceptionally and in early pregnancy. Women with an HbA1c above 10% have up to a 25% chance of a fetal abnormality being present. Women are at an increased risk of fetal loss throughout pregnancy; again this is related to glycaemic control.</p>
                            <p>Although fetal macrosomia is the most common fetal growth pattern in diabetes, in women with pre-existing vascular disease and those who develop early preeclampsia, fetal growth restriction can be a problem.</p>
                            <p>Women with hypertension and diabetic nephropathy are at high risk of developing pre-eclampsia (approximately 30%).</p>

                            <div class="table-wrapper">
                                <div class="table-header">
                                    <span class="table-icon">üìä</span>
                                    <span class="table-caption">Table 9.5 Risks of pre-existing diabetes in pregnancy</span>
                                </div>
                                <div class="table-container">
                                    <table class="content-table">
                                        <thead>
                                            <tr>
                                                <th></th>
                                                <th style="text-align: center;">Maternal concerns</th>
                                                <th style="text-align: center;">Fetal/neonatal concerns</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td style="text-align: center;">First trimester</td>
                                                <td style="text-align: center;">Increased insulin requirements</td>
                                                <td style="text-align: center;">Miscarriage<br>Fetal abnormality</td>
                                            </tr>
                                            <tr>
                                                <td style="text-align: center;">Second trimester<br>Third trimester</td>
                                                <td style="text-align: center;">Pre-eclampsia<br>Recurrent infections<br>Worsening retinopathy if vascular disease</td>
                                                <td style="text-align: center;">Macrosomia<br>Polyhydramnios<br>Stillbirth<br>Growth restriction</td>
                                            </tr>
                                            <tr>
                                                <td style="text-align: center;">Labour</td>
                                                <td style="text-align: center;">Induction of labour<br>Poor progress in labour</td>
                                                <td style="text-align: center;">Preterm delivery</td>
                                            </tr>
                                            <tr>
                                                <td style="text-align: center;">Delivery</td>
                                                <td style="text-align: center;">Instrumental birth<br>Birth trauma<br>caesarean section</td>
                                                <td style="text-align: center;">Shoulder dystocia</td>
                                            </tr>
                                            <tr>
                                                <td style="text-align: center;">Postnatal</td>
                                                <td style="text-align: center;">Return to pre-pregnancy control within hours of birth</td>
                                                <td style="text-align: center;">Neonatal hypoglycaemia<br>Neonatal unit admission<br>Respiratory distress syndrome<br>Jaundice</td>
                                            </tr>
                                            <tr>
                                                <td style="text-align: center;">Longer term</td>
                                                <td style="text-align: center;">-</td>
                                                <td style="text-align: center;">Diabetes in childhood (2‚Äì3% if mother has type 1; 10‚Äì15% if mother has type 2)</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>

                            <h4>Management</h4>
                            <p>Preconception counselling in diabetic women enables a woman to be informed about pregnancy and diabetes and also allows women to consider the best time to try to conceive. As many of the complications of diabetes relate to the level of glycaemic control, the aim is to get the HbA1c less than 6.1% before conception. If this is achieved the complication rate of pregnancy in women with diabetes is not much greater than the normal population. Medications can be reviewed. Insulins, both traditional and the newer agents, have been shown to be safe in pregnancy. Metformin is usually continued but other oral hypoglycaemic agents usually stopped. Consequently many women with type 2 diabetes will require insulin in pregnancy. However, some of the medications used to treat the complications of diabetes are not safe, for example, angiotensinconverting enzyme (ACE) inhibitors used in the treatment of diabetic nephropathy should be stopped in pregnancy. Women with diabetes should take a higher (5 mg rather than the normal 400 Œºg) periconceptual dose of folic acid in view of the increased risk of neural tube defects.</p>
                            <p>Multi-disciplinary team working is key in managing women with diabetes. Obstetric diabetes clinics will often consist of an obstetrician, endocrinologist, diabetes specialist nurse, dietician and specialist midwife. Women will be seen regularly throughout pregnancy by this team.</p>
                            <p>The metabolic goal during pregnancy is to maintain blood glucose as close to the normal range as possible, while avoiding severe hypoglycaemia. This involves increasing capillary blood glucose monitoring and tightening control more than is usual outside of pregnancy. The target levels are the same as given in gestational diabetes section (above). Because women are encouraged to keep glucose control tight they can experience unpleasant attacks of hypoglycaemia. Various measures (oral glucose preparations and/or IM glucagon) need to be in place to deal with this complication.</p>
                            <p>Fetal assessment for abnormalities involves combined testing for chromosomal problems (if the mother wishes) in the first trimester and a routine anatomy scan at 20 weeks. Additional scanning to look at cardiac anatomy is sometimes recommended in view of the increased risk of congenital cardiac disease. Regular serial growth scans can detect both macrosomia and fetal growth restriction.</p>
                            <p>For maternal wellbeing, low dose aspirin from the second trimester can reduce the risk of pre-eclampsia developing. In women with vascular disease care should be taken to keep blood pressure well controlled to reduce the risk of disease deterioration. All women with preexisting diabetes should have an ophthalmic assessment in each trimester for evidence of development of worsening of diabetic retinopathy.</p>
                            <p>Women with diabetes should give birth in a hospital with neonatal facilities. Delivery plans will depend on the stability of diabetes in pregnancy and maternal and fetal wellbeing; however, delivery at around 38‚Äì39 weeks is usually recommended. Vaginal birth is often planned but caesarean section rates are high in this group of women. The fetus should be monitored continuously. The neonates are at risk of neonatal hypoglycaemia. This risk can be reduced by strict glycaemic control in labour and a sliding scale infusion of insulin-dextrose is often required to achieve this control in women with preexisting diabetes.</p>
                            <p>Postnatally, women return to pre-pregnancy treatment regimens as soon as they are delivered and eating and drinking.</p>

                            <h3>Thyroid disease in pregnancy</h3>
                            <p>Thyroid disorders of various types complicate approximately 1‚Äì1.5% of pregnancies. Increased oestrogen in normal pregnancy leads to an increase in thyroid-binding globulin that necessitates an increased production of thyroid hormone to maintain free T4 and T3 levels. These changes, along with a fall in iodine levels in the maternal plasma due to increased renal loss, result in an enlargement of the thyroid gland of 10‚Äì20%. A fall in the thyroid-stimulating hormone (TSH) levels is also a feature of the first half of pregnancy, which may be explained by thyroid stimulatory effects of human chorionic gonadotrophin.</p>

                            <h4>Hypothyroidism</h4>
                            <p>Hypothyroidism is the commonest thyroid problem to occur in pregnancy and complicates around 1% of pregnancies. Most cases have a basis in autoimmune diseases, where autoantibodies like thyroid peroxidase, and those associated with Hashimoto's disease cause gland destruction and fibrosis. Hypothyroidism may also be iatrogenic as the consequence of thyroidectomy, radio-iodine ablation or excessive doses of antithyroid drugs.</p>
                            <p><strong>Implications of pregnancy on the disease:</strong> There are few effects of pregnancy on hypothyroidism. An increase in replacement therapy is usually required, although this relates more to effects on the fetus than maternal effects.</p>
                            <p><strong>Implications of the disease on pregnancy:</strong> Maternal and fetal outcomes are worse with overt hypothyroidism. There are increased risks of spontaneous abortion, pre-eclampsia, pregnancy-induced hypertension, postpartum haemorrhage and low birth weight. There is a risk of a slight reduction in IQ in the infant but no increased risk in congenital malformations. Women with subclinical hypothyroidism (women on thyroxine replacement) have better outcomes although there is some evidence that the effects on IQ remain. With adequate replacement, pregnancy outcomes are excellent.</p>
                            <p><strong>Management:</strong> Thyroid function testing in these women should be performed every trimester, and replacement should be adjusted as T4 levels fall due to the increase in maternal extracellular fluid levels. The diagnosis of inadequate treatment/hypothyroidism in the mother is made by a raised level of TSH.</p>
                            <p>Where hypothroidism is secondary to treatment for hyperthyroidism, neonatal surveillance for neonatal thyroid dysfunction secondary to transplacental transmission of thyroid antibodies.</p>
                            <p>Iodine deficiency in many countries is endemic. Untreated it is associated with poor fetal outcomes from miscarriage, stillbirth, neonatal death and congenital abnormalities including cretinism. All pregnant women should be encouraged to ensure an adequate iodine intake in pregnancy; if necessary through supplementation. Where the mother is receiving adequate replacement therapy, the outcome for the infant is normal.</p>

                            <h4>Hyperthyroidism</h4>
                            <p>Hyperthyroidism occurs in approximately 0.2% of pregnancies, 95% of which are due to Graves' disease. Diagnosis is made by the finding of elevated T4 and T3 levels associated with a lowered TSH level.</p>
                            <p><strong>Implications of pregnancy on the disease:</strong> Pregnancy is usually associated with an increased requirement for thyroxine. Women being treated for hyperthyroidism often need less treatment in pregnancy, however postpartum flares are common. Untreated thyrotoxicosis can result in a thyroid crisis and heart failure in pregnancy.</p>
                            <p><strong>Implications of the disease on pregnancy:</strong> Uncontrolled hyperthyroidism is associated with higher rates of pre-eclampsia, fetal growth restriction, prematurity, stillbirths and thyrotoxicosis in the fetus.</p>
                            <p>Neonatal thyrotoxicosis occurs in 1% of babies. This is transient and due to the transfer of TSH receptor antibodies across the placenta.</p>
                            <p><strong>Management:</strong> Thyroid function testing should be carried out every four to six weeks and therapy adjusted accordingly. Most antithyroid medications are safe in pregnancy but specialist advice from an endocrinologist should be sought.</p>
                            <p>Serial growth measurements and regular assessment of fetal heart rate (looking for fetal thyroid dysfunction) is advisable.</p>
                            <p>A prolonged postnatal hospital stay may be required to assess the neonate for signs of thyrotoxicosis.</p>

                            <h3>Obesity</h3>
                            <p>The impact of obesity in pregnancy is increasing. Prevalence is dependent on the population served, though a national survey in the UK in 2009 found that in 9.3 per 100 000 maternities women had a BMI of more than 50 (UK Obesity Surveillance System). Women with obesity often feel stigmatized, however obesity is associated with significant medical problems in pregnancy that must be addressed. Obese women are more likely to suffer with co-morbidities such as hypertension, sleep apnoea, diabetes and cardiovascular disease all of which can increase further the risks of pregnancy.</p>

                            <h4>Implications of pregnancy on obesity</h4>
                            <p>The optimum weight gain in pregnancy has not been established. However in obese women it is prudent to minimize weight gain during the antenatal period.</p>

                            <h4>Implications of obesity on pregnancy</h4>
                            <p>Antenatally, obesity is associated with a number of maternal and fetal complications. In the first trimester the risk of miscarriage and congenital abnormality (especially neural tube defects) is increased, the aetiology of this has not been established. Throughout pregnancy there is an increased risk of venous thromboembolism. Later in pregnancy obese women are more likely to develop preeclampsia and gestational diabetes. In addition, many minor complications of pregnancy such as gastrooesophageal reflux and pelvic girdle dysfunction are more likely to occur in women with a raised body mass index.</p>
                            <p>Obesity is associated with fetal macrosomia; however, maternal adiposity can have significant impact on the ability to accurately determine fetal size both clinically and using ultrasound. There is an increased risk of stillbirth and neonatal death. In the long term, children of obese mothers are more likely to have childhood obesity and juvenile diabetes.</p>
                            <p>Obese women are more likely to have an induction of labour, to have poor progress in labour and a caesarean section. This higher rate of caesarean births in obese women is thought to be secondary to a combination of fetal macrosomia, co-morbid conditions and the hormonal effect of adipose tissue on labour.</p>
                            <p>The risks of caesarean section, both anaesthetic and obstetric, are higher in women with a higher body mass index. If vaginal birth is achieved, shoulder dystocia and extended perineal tears are more frequent. There is a higher risk of postpartum haemorrhage.</p>

                            <div class="table-wrapper">
                                <div class="table-header">
                                    <span class="table-icon">üìä</span>
                                    <span class="table-caption">Table 9.6 Risks of obesity in pregnancy</span>
                                </div>
                                <div class="table-container">
                                    <table class="content-table">
                                        <thead>
                                            <tr>
                                                <th></th>
                                                <th style="text-align: center;">Maternal risks/complications</th>
                                                <th style="text-align: center;">Fetal/neonatal risks/complications</th>
                                            </tr>
                                        </thead>
                                        <tbody>
                                            <tr>
                                                <td style="text-align: center;">First trimester</td>
                                                <td style="text-align: center;">Venous thromboembolism</td>
                                                <td style="text-align: center;">Miscarriage<br>Fetal abnormality</td>
                                            </tr>
                                            <tr>
                                                <td style="text-align: center;">Second trimester<br>Third trimester</td>
                                                <td style="text-align: center;">Pre-eclampsia<br>Gestational diabetes<br>Venous thromboembolism</td>
                                                <td style="text-align: center;">Macrosomia<br>Stillbirth<br>Difficulty with fetal assessment</td>
                                            </tr>
                                            <tr>
                                                <td style="text-align: center;">Labour</td>
                                                <td style="text-align: center;">Induction of labour<br>Poor progress in labour</td>
                                                <td style="text-align: center;">-</td>
                                            </tr>
                                            <tr>
                                                <td style="text-align: center;">Delivery</td>
                                                <td style="text-align: center;">Instrumental birth<br>Traumatic birth<br>Caesarean section<br>Anaesthetic complications (difficulties with intubation or epidural insertion)</td>
                                                <td style="text-align: center;">Shoulder dystocia</td>
                                            </tr>
                                            <tr>
                                                <td style="text-align: center;">Postnatal</td>
                                                <td style="text-align: center;">Postpartum haemorrhage<br>Venous thromboembolism</td>
                                                <td style="text-align: center;">Neonatal unit admission<br>Neonatal death</td>
                                            </tr>
                                            <tr>
                                                <td style="text-align: center;">Longer term</td>
                                                <td style="text-align: center;">-</td>
                                                <td style="text-align: center;">Childhood obesity<br>Juvenile diabetes</td>
                                            </tr>
                                        </tbody>
                                    </table>
                                </div>
                            </div>

                            <h4>Management</h4>
                            <p>Ideally, preconceptual counselling would allow women to defer pregnancy until a nearer normal body mass index is achieved, but this rarely occurs.</p>
                            <p>Women with obesity should have hospital-based care because of the associated risks in pregnancy and at birth. Support from a dietician should be offered with the aim of achieving a more healthy diet rather than weight reduction. Folic acid should be taken until 12 weeks. Some authorities recommend a higher dose (5 mg) in view of the increased risk of neural tube defects but evidence for this is lacking. A thorough assessment for other risk factors for pre-eclampsia and venous thromboembolism should be performed. Based on this aspirin to reduce the risk of pre-eclampsia or thromboprophylaxis to reduce the risk of venous thromboembolism may be appropriate. A glucose tolerance test to screen for gestational diabetes should be offered in the late second trimester.</p>
                            <p>The efficacy of routine ultrasound screening for anomalies is reduced in obese women because of poor visualization. Furthermore, although clinical assessments of fetal growth are limited by maternal habitus there is little evidence that ultrasound provides a more accurate assessment again because of poor visualization.</p>
                            <p>In view of the potential complications of labour and birth, obese women should deliver in a hospital unit. If there are no other contra-indications to vaginal birth this should be planned.</p>

                            <h3>Thrombophilia</h3>
                            <p>Thrombophilia can be heritable or acquired. Inherited thrombophilias are found in approximately 15% of the Caucasian population, the most common being factor V Leiden. The most common acquired thrombophilia is antiphospholipid syndrome that is associated with a number of adverse outcomes in pregnancy. Thromophilias are responsible for 20‚Äì50% of venous thromboembolic events in pregnancy.</p>

                            <h4>Implications of pregnancy on the disease</h4>
                            <p>Pregnancy is a prothrombotic state and as such women with thrombophilia are at particular risk of venous thromboembolism during this time. Different thrombophilias are associated with differing levels of risks of clotting and management must be individualized accordingly.</p>

                            <h4>Implications of the disease on pregnancy</h4>
                            <p>Thrombophilias (both inherited and acquired) are known to be associated with obstetric problems in addition to their risks of venous thromboembolism. For example in women with factor V Leiden associations with fetal loss, pre-eclampsia, placental abruption and in utero growth restriction have all been described. Adverse pregnancy outcomes including recurrent miscarriage, fetal death and premature birth secondary to placental disease form part of the definition of antiphospholipid syndrome.</p>

                            <h4>Screening</h4>
                            <p>Screening for thrombophilias should be considered in women with a personal or family history of venous thromboembolism and women with a poor obstetric history such as recurrent miscarriage, stillbirth, early onset preeclampsia and abruption. However screening tests performed in pregnancy can be difficult to interpret because of the changes in the haemopoetic system. Ideally these should be performed either postnatally after an adverse event (allowing time for resolution of pregnancy changes to occur) or in the setting of preconceptual counselling.</p>

                            <h4>Management</h4>
                            <p>Women with thrombophilia should be ideally seen in a combined obstetric-haematology clinic. Input from a haematologist is key when planning care for the large spectrum of disorders with their varying risks of thrombosis and pregnancy-related morbidity. A full assessment of all risk factors for venous thromboembolism in addition to the thrombophilia will allow decisions about the appropriate prophylaxis to be made: whether this be antenatal and/or postnatal LMWH or avoiding dehydration and the use of graduated compression stockings.</p>
                            <p>As previously discussed, LMWH is safe for use in pregnancy but care should be taken to make a plan for its use around the time of birth to minimize the risks of bleeding and ensure that a woman has the full range of analgesic options available to her. In terms of the other obstetric risks of thrombophilias, with the exception of antiphospholipid syndrome, it is unclear if treatment with aspirin or heparin improves pregnancy outcome. However, for women with antiphospholipid syndrome there is some evidence that the use of aspirin (and possibly heparin) does reduce the incidence of pregnancy complications.</p>

                            <h3>Epilepsy</h3>
                            <p>Epilepsy affects approximately 1% of the obstetric population.</p>

                            <h4>Implications of pregnancy on the disease</h4>
                            <p>The effect of pregnancy on epilepsy is variable. Usually the seizure frequency is unchanged, but a minority of women will have increased seizures. This is thought to be due to non-compliance with medication and sleep deprivation rather than an effect of the pregnancy per se.</p>
                            <p>There is a suggestion that the risk of sudden unexplained death in epilepsy is increased in pregnancy. However, again this may relate to non-compliance with medication rather than an underlying pregnancy effect.</p>

                            <h4>Implications of disease on pregnancy</h4>
                            <p>In women with epilepsy there is a higher risk of congenital abnormalities (3% compared with 1‚Äì2% in the general population), this risk is increased further if a woman is taking anti-epileptic drugs (4‚Äì9%). The perinatal loss rate is higher. Tonic-clonic seizures and in particular status epilepticus are associated with fetal loss.</p>
                            <p>The probability of having a child with epilepsy is increased if either parent has epilepsy, approximately 4‚Äì5% but increases to up to 20% if both parents are affected.</p>

                            <h4>Medications</h4>
                            <p>Different anti-epileptic medications have different effects on the fetus. Sodium valproate appears to have the greatest risk and should be avoided if possible in women of reproductive age. The risks to the fetus of anti-epileptic medication include congenital abnormalities (mainly neural tube defects and congenital heart abnormalities), in utero growth restriction and more subtle long-term neurodevelopmental effects. The effects are increased when more than one anti-epileptic drug is being taken. Carbamazepine and lamotrigine are considered to be the safest antiepileptic drugs for use in pregnancy.</p>
                            <p>Often anti-epileptic drug levels fall in pregnancy and rise in puerperium, so drug doses may need to be altered to maintain seizure control.</p>
                            <p>Some anticonvulsant medications induce vitamin K deficiency that can lead to an increased risk of haemorrhagic disease of the newborn.</p>
                            <p>The overall aim is to be on the fewest medications at the lowest dose commensurate with the epilepsy remaining controlled.</p>

                            <h4>Management</h4>
                            <p>Ideally women with epilepsy should be seen preconceptually for counselling about their risks in pregnancy and to review their medications. Medications may need to be altered and sometimes it is appropriate to advise delaying pregnancy until a 'safer' drug regimen is established. Women should be advised not to abruptly stop their medication because of fears about the fetus and it should be emphasized that the risk of uncontrolled epilepsy is likely to be greater than the risks of the medications being taken. A higher 5 mg dose of folic acid is recommended periconceptually and in the first trimester due to the increased risk of neural tube defects.</p>
                            <p>Women should be managed by a multi-disciplinary team with the aim of avoiding seizures in pregnancy. Combined screening for chromosomal disorders and anatomy scanning can be performed as normal. Serial growth scans may be required, particularly if a woman is on more than one medication. If anti-epileptic medication that induces vitamin K deficiency is being taken, vitamin K can be given to the mother in the last few weeks of pregnancy and the baby can receive intramuscular vitamin K just after birth to reduce the risk of hemorrhagic disease of the newborn.</p>
                            <p>Although women worry about seizures occurring in labour, given the tiredness and stress of this time, this is uncommon, but delivery in a hospital unit is advisable.</p>
                            <p>Women with epilepsy should be given advice antenatally and after delivery regarding safe practices when looking after their newborn, such as not bathing the baby on their own and changing the baby on the floor rather than a high changing table.</p>
                            <p>Breastfeeding is safe for women on most anti-epileptic medications.</p>

                            <h3>Migraine</h3>
                            <p>Headaches are common in pregnancy. The most common are migraine and those due to tension. New onset headaches, especially those associated with focal or abnormal neurological signs, impaired intellect and pain that impairs sleep, need specialist assessment.</p>
                            <p>In women who suffer migraine before pregnancy, the frequency of attacks drops by 50‚Äì80% during pregnancy, but increases again in the puerperium. If an attack does occur the initial treatment comprises simple analgesia, avoidance of light, bed rest and various coping mechanisms. If these simple measures do not work and the migraine is persistent then more potent analgesics, Œ≤-blockers and/or tricyclic antidepressants have all been used with success. The ergot derivatives often used as prophylaxis/treatment outwith pregancy are contraindicated due to their vasoconstrictive effects.</p>

                            <h3>Cardiac disease</h3>
                            <p>There has been a large increase in cardiac disease in pregnancy in recent years. Although some of this is explained by women who themselves have had congenital heart disease now having children, the majority is acquired. Cardiac disease is now the main cause of indirect maternal death in the UK. A multitude of cardiac conditions can be encountered in pregnancy, including valvular lesions, congenital heart disease, cardiomyopathies, arrhythmias and ischaemic heart disease.</p>

                            <h4>Implications of pregnancy on the disease</h4>
                            <p>Pregnancy puts a great strain on the maternal cardiovascular system. The necessary rise in cardiac output can result in deterioration of some conditions, such as aortic stenosis, as these women have a fixed cardiac output. In other conditions, such as regurgitant lesions, pregnancy can be well tolerated.</p>
                            <p>Many symptoms of cardiac disease are also symptoms of pregnancy, such as breathlessness, palpitations and syncope; cardiovascular signs are also mimicked by pregnancy (bounding pulse, systolic murmur) and as it can be difficult to diagnose a new cardiac condition or deterioration in a known cardiac condition.</p>
                            <p>Depending on the underlying heart condition, women can be at risk in pregnancy of the following conditions:</p>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">congestive cardiac failure</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">worsening hypoxia</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">arrhythmias and sudden death</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">bacterial endocarditis</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">venous thromboembolism</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">angina and myocardial infarction</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">aortic dissection.</span>
                                </li>
                            </ul>

                            <h4>Implications of the disease on pregnancy</h4>
                            <p>Again, the implications of cardiac disease on the pregnancy will depend on the specific cardiac problem. However increased risks include pre-eclampsia, intrauterine growth restriction, preterm birth and fetal loss. Some medications taken in these conditions such as ACE inhibitors and warfarin are teratogenic and their use will need to be reviewed as to whether there is a suitable alternative or if, on balance, the medication should be continued. In women with congenital heart disease, there is an increased risk of congenital heart disease in their children of up to 5%.</p>

                            <h4>Management</h4>
                            <p>Multi-disciplinary management between obstetricians, cardiologists and obstetric anaesthetists should ideally start at the preconception phase. For some women with poor cardiac functional status pregnancy may not be advisable. The risk of maternal death can be extremely high in some conditions, for example, in women with Eisenmenger's syndrome maternal death rates of 40‚Äì50% are described.</p>
                            <p>Although the New York Heart Association classification provides some information about possible prognosis (Box 9.2) care plans should be individualized. Antenatally, stressors such as anaemia and infection should be minimized. Medication may need to be altered in some women and anticoagulation may also be required. Fetal surveillance may include serial growth scans and Doppler measurements as well as screening for cardiac defects. Maternal surveillance may involve regular echocardiograms.</p>
                            
                            <aside class="callout callout--note">
                                <div class="callout-header">
                                    <span class="callout-icon">üìã</span>
                                    <span class="callout-title">Box 9.2 New York Heart Association classification</span>
                                </div>
                                <div class="callout-content">
                                    <ul class="enhanced-list">
                                        <li class="list-item">
                                            <span class="list-marker"></span>
                                            <span class="list-content"><strong>Grade 1:</strong> Normal exercise tolerance</span>
                                        </li>
                                        <li class="list-item">
                                            <span class="list-marker"></span>
                                            <span class="list-content"><strong>Grade 2:</strong> Breathless on moderate exertion</span>
                                        </li>
                                        <li class="list-item">
                                            <span class="list-marker"></span>
                                            <span class="list-content"><strong>Grade 3:</strong> Breathless on less than moderate exertion</span>
                                        </li>
                                        <li class="list-item">
                                            <span class="list-marker"></span>
                                            <span class="list-content"><strong>Grade 4:</strong> Breathless at rest without significant activity</span>
                                        </li>
                                    </ul>
                                </div>
                            </aside>

                            <p>Labour is a problematic time and attempts should be made to minimize pain and ensure fluid balance is diligently maintained. The haemodynamic changes that occur in the immediate postpartum period mean that this is often the most risky time for women with cardiac disease and careful surveillance and joint management by the obstetric, cardiac and anaesthetic teams is vital.</p>

                            <h3>Respiratory disorders</h3>
                            <p>Respiratory disease, predominantly asthma, is common in pregnancy. As with the assessment of cardiac disease, differentiating physiological changes from pathological ones can be difficult as women experience a sense of breathlessness (dyspnoea) that increases from early pregnancy to peak at 30 weeks.</p>

                            <h4>Asthma</h4>
                            <p>Asthma is an increasingly common disorder and can be expected to affect 5‚Äì10% of pregnant women.</p>
                            <p><strong>Implications of pregnancy on the disease:</strong> The effect of pregnancy on asthma is not predictable, although approximately one-third of women will improve, one-third will get worse, and one-third stay the same. Approximately 10% of women with asthma will have an acute exacerbation in pregnancy.</p>
                            <p><strong>Implications of the disease on pregnancy:</strong> Women with well-controlled asthma have good pregnancy outcomes and there are no established adverse effects of well-controlled asthma on pregnancy. In contrast, women with poorly controlled asthma or those with severe exacerbations in pregnancy are at increased risk of fetal growth restriction, premature birth and pre-eclampsia.</p>
                            <p><strong>Management:</strong> Baseline peak flow measurements should be taken at the start of pregnancy. Women should be encouraged to continue their asthma medication as a significant number of exacerbations are caused by cessation of medication due to concerns about the effects on the fetus. Most asthma medications are safe in pregnancy (including steroid therapy), although there is less information about some of the newer therapies. The management of acute excerbations of asthma is the same in pregnancy as in nonpregnant asthmatics.</p>

                            <h4>Cystic fibrosis</h4>
                            <p>Although cystic fibrosis (CF) is ultimately a fatal disease, the life expectancy of a sufferer has markedly increased in the last 30 years due to early diagnosis and improvements in treatment. The incidence of CF is 0.05‚Äì0.1% of births in Caucasian populations in which 5% of adults carry the recessive gene. The increased life expectancy has provided opportunities for women with CF to consider pregnancy. As a result, women with CF account for 0.4‚Äì0.8% of pregnancies in US and UK, with up to 80% achieving a live birth.</p>
                            <p><strong>Implications of pregnancy on the disease:</strong> Although pregnancy can be tolerated well, many women do experience difficulties as the effects on lung function can be unpredictable and maintaining adequate nutrition can be problematic. The risks of pregnancy relate to the degree of pulmonary dysfunction. In women with poor lung function, significant decline can occur in pregnancy that may be irreversible.</p>
                            <p><strong>Implications of the disease on pregnancy:</strong> As an autosomal recessive condition there is a risk of transmission of the disease to the infant. Prenatal diagnosis can be offered. There is an increased risk of gestational diabetes due to fibrosis in the pancreas. Around one-third of babies of women with CF will be born preterm; growth restriction may be an issue in those with poor nutritional status.</p>
                            <p><strong>Management:</strong> Ideally pregnancies should be planned and pre-pregnancy advice sought. This involves genetic counselling, the optimization of treatment of lung and gastrointestinal function, and an assessment for pulmonary hypertension. Significantly raised pulmonary pressures are associated with a high maternal mortality and pregnancy should be avoided. High-dose folate (5 mg/day) should be taken periconceptually to reduce the risk of fetal anomaly.</p>
                            <p>Multidisciplinary care is essential, including obstetricians, respiratory physicians and obstetric anaesthetists. Pulmonary function tests should be performed at the start of pregnancy and repeated according to symptoms.</p>
                            <p>Nutritional support is mandatory and specialist dieticians should be able to advise on the necessary supplements. Chest infections should be treated promptly.</p>
                            <p>Women should be screened for gestational diabetes with a glucose tolerance test.</p>

                            <h3>Autoimmune disease</h3>
                            <p>Autoimmune disease is five times more common in women than men. Systemic lupus erythematosis (SLE), scleroderma, antiphospholipid syndrome and thyroid disorders (discussed above) all can have an effect on placental function and result in miscarriage, fetal growth restriction, early onset severe pre-eclampsia, thrombosis, and fetal death. Some autoimmune conditions, such as rheumatoid arthritis and Crohn's disease, improve in the altered steroid environment of pregnancy, but there is a serious increased risk of relapse during the puerperium.</p>

                            <h4>Systemic lupus erythematosis</h4>
                            <p>SLE is a multisystem disorder characterized by periods of relapse and remission. The diagnosis of SLE is dependent on the serological finding of the antinuclear antibody (ANA) in the serum and at least 4 of 11 other clinical or laboratory criteria published by the American Rheumatology Association, including rash, renal impairment, arthritis, and thrombocytopenia.</p>
                            <p><strong>Implications of pregnancy on the disease:</strong> There is some evidence that relapses occur more frequently in pregnancy, and there certainly an increase in flares in the postnatal period. Women with lupus nephritis are at risk of deterioration in their renal function that may be irreversible (see the previous section on chronic renal diseases).</p>
                            <p><strong>Implications of the disease on pregnancy:</strong> Women with SLE are at increased risk of early miscarriage, stillbirth, early onset pre-eclampsia, in utero growth restriction and pre-term birth. The likelihood of these occurring is increased if they have renal involvement or if they have antiphospholipid syndrome (APS) in addition.</p>
                            <p>Women, especially those with APS alongside their SLE, are at increased risk of venous thromboembolism.</p>
                            <p>Infants are at risk of neonatal lupus and congenital heart block.</p>
                            <p><strong>Management:</strong> Women should be managed by a multidisciplinary team with the opportunity for pre-pregnancy counseling. Outcomes are better if pregnancy is avoided until at least six months after a 'flare'.</p>
                            <p>Women should be advised to take low dose aspirin to reduce the risk of pre-eclampsia and low molecular weight heparin should be used in addition where APS co-exists.</p>
                            <p>The disease should be monitored by symptom review and regular assessment of disease markers. Immunosuppression can be continued in women with severe lupus although the agents used may need to be changed if teratogenic.</p>
                            <p>Labour is usually induced at 37‚Äì38 weeks to avoid late pregnancy thrombotic complications</p>

                            <h3>Haemoglobinopathies</h3>
                            <h4>Sickle cell syndromes</h4>
                            <p>These genetic disorders involve abnormalities in haemoglobin synthesis resulting in abnormal S haemoglobin being produced. The disease spectrum can range from the relatively asymptomatic sickle cell trait where women are heterozygous for the sickle gene, through to homozygous sickle cell disease where women can have regular sickle cell crises. Although there is a strong link with certain ethnicities, especially those from sub-Saharan Africa and the Middle East, sickle cell syndromes are now seen throughout the world.</p>
                            <p><strong>Implications of pregnancy on the disease:</strong> The frequent pregnancy complications of nausea and vomiting, anaemia and infection can all increase the likelihood of a sickle cell crisis occurring in women with sickle cell disease and so pregnancy can result in an increased frequency of crises.</p>
                            <p><strong>Implications of the disease on pregnancy:</strong> The genetic implications of the sickle cell syndromes depend on the status of the partner and so early partner testing is recommended. Depending on the result of this, women may need input from the genetics team to determine if they wish to proceed with prenatal diagnosis.</p>
                            <p>Women with the sickle cell trait generally do well in pregnancy, although anaemia and infections can be a problem. In contrast, sickle cell disease is associated with significant obstetric complications including increased fetal risks of miscarriage, preterm birth, in utero growth restriction and perinatal mortality; there are also increased maternal risks of venous thromboembolism and pre-eclampsia.</p>
                            <p><strong>Management:</strong> Women whose partners also carry the sickle gene can be offered prenatal diagnosis if desired. All women with sickle cell syndromes should be advised to take a higher dose (5 mg) of folic acid to reduce the risk of neural tube defects as their haemolytic anaemia increases their risk of folate deficiency. In women with sickle cell disease, lowdose aspirin should be considered to reduce the risk of pre-eclampsia and prophylactic antibiotics to reduce the risks of infection. Serial growth scans should be performed to look for evidence of growth problems. Anaemia can worsen during pregnancy and blood transfusions may be required to maintain an adequate haemoglobin level. If crises occur they should be treated promptly to reduce the risk to the fetus.</p>
                            <p>During pregnancy and labour, dehydration should be avoided and the need for venous thromboembolism prophylaxis should be regularly assessed depending on other risk factors.</p>

                            <h4>The thalassaemias</h4>
                            <p>These disorders are associated with a reduction in the rate of production of the alpha- and beta-globin chains of haemoglobin. In alpha-thalassaemia, the degree of impairment depends on the number of alpha-globin genes absent with one absent causing minimal symptoms and four being incompatible with life. Most of the women with alpha-thalassaemia who become pregnant will have one or two alpha genes missing and will have mild anaemia. In beta-thalassaemia individuals can be homozygous or heterozygous resulting again in a spectrum of symptomatology. Women with homozygous betathalassaemia rarely become pregnant; however, women with heterozygous beta-thalassaemia have minimal symptoms and no impairment to pregnancy.</p>
                            <p><strong>Implications of pregnancy on the disease:</strong> Pregnancy can cause a significant worsening of the mild anaemia seen in many women with thalassaemias.</p>
                            <p><strong>Implications of the disease on pregnancy and management:</strong> The main implication of the thalassaemias on pregnancy is the risk of inheritance of the thalassaemia genes. Partner testing will identify women who are at risk of carrying a homozygous fetus who can then be referred for prenatal testing. Problematic anaemia may need to be treated with transfusions in pregnancy. Iron therapy must be used cautiously as women are at risk of iron overload.</p>
                        </div>
                    </section>

                    <!-- Conclusion -->
                    <section id="conclusions" class="content-section">
                        <div class="section-header">
                            <h2 class="section-title">
                                <span class="title-icon">üîö</span>
                                CONCLUSIONS
                            </h2>
                        </div>
                        <div class="content-card">
                            <p>It is essential to have a framework for considering the implications of medical conditions in pregnancy. These now are responsible for an increasing number of maternal deaths and adequate understanding is essential if this trend is to be reversed.</p>
                        </div>
                    </section>

                    <!-- Essential Information -->
                    <aside class="key-points-section" role="region" aria-labelledby="key-points-title">
                        <div class="key-points-wrapper">
                            <div class="key-points-header">
                                <span class="key-points-icon">‚≠ê</span>
                                <h3 id="key-points-title" class="key-points-title">Essential information</h3>
                            </div>
                            <ul class="key-points-list">
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Minor complaints in pregnancy</strong>: These are usually due to physiological changes in pregnancy, but it is important to ensure there is not a pathological cause</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Anaemia</strong>:
                                        <ul style="margin-top: 0.5rem; margin-bottom: 0; color: white;">
                                            <li>In the UK, this is defined as a haemoglobin level &lt;11 g/dL (some use &lt;10.5 g/dL) especially towards the start of the third trimester</li>
                                            <li>Usually caused by: Inadequate intake of dietary iron, Impaired absorption of iron (gastric achlorhydria, malnutrition, chronic diarrhoea, hookworm)</li>
                                            <li>Investigations ‚Äì MCV, HCHC, serum iron and irontbinding, ferritin folate and vitamin B12; others if cause still obscure</li>
                                            <li>Management usually with oral iron/folic acid</li>
                                        </ul>
                                    </p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Diabetes</strong>:
                                        <ul style="margin-top: 0.5rem; margin-bottom: 0; color: white;">
                                            <li>Classified as type 1, type 2, or gestational</li>
                                            <li>Needs strict management with the aim of keeping capillary glucose in the non-diabetic range</li>
                                            <li>Management by diet and insulin (type 1); diet, oral hypoglycaemic agents ¬± insulin (type 2); diet ¬± oral hypoglycaemic agents ¬± insulin (gestational diabetes)</li>
                                        </ul>
                                    </p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Infections acquired in pregnancy</strong>:
                                        <ul style="margin-top: 0.5rem; margin-bottom: 0; color: white;">
                                            <li>Some infections in pregnancy can adversely affect the mother and the fetus though not always equally seriously</li>
                                            <li>Vertical transmission of HIV can be reduced to a minimum by anti-retroviral therapy during pregnancy. If virus is detectable at the end of pregnancy elective delivery by caesarean section is recommended</li>
                                            <li>The main management strategy in women with either hepatitis, A, B or C is to implement a variety of measures to prevent vertical transmission, though an elective caesarean section does not appear to help this</li>
                                            <li>The main risk of tuberculosis in pregnancy is on the health of the woman. Placental transfer is rare. Steptomycin is the only anti-tuberculous drug that is contraindicated</li>
                                            <li>Asymptomatic and symptomatic bacteriuria are common infections in pregnancy and prompt recognition and treatment is necessary to prevent progression to peyelonephritis</li>
                                            <li>Some infections can be prevented by prior immunization and some can be treated effectively during pregnancy</li>
                                        </ul>
                                    </p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Thromboembolism</strong>:
                                        <ul style="margin-top: 0.5rem; margin-bottom: 0; color: white;">
                                            <li>This is one of the major causes of maternal deaths</li>
                                            <li>A previous history of the condition and hereditary conditions with increased coagulability increase the risk</li>
                                            <li>Every mother should be assessed in the antenatal period, during labour and postpartum for the possible risk and prophylactic measures (especially using low molecular weight heparin) should be undertaken</li>
                                            <li>If a deep vein thrombosis or pulmonary embolism is suspected clinically full anticoagulation should be commenced until the results investigations are available. If the diagnosis is not confirmed the treatment is stopped</li>
                                        </ul>
                                    </p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Liver disease</strong>:
                                        <ul style="margin-top: 0.5rem; margin-bottom: 0; color: white;">
                                            <li>Obstetric cholestasis is of uncertain aetiology.</li>
                                            <li>It produces intense itching of the woman's palms and soles of feet</li>
                                            <li>It is associated with an increased risk of fetal death and elective delivery at 37‚Äì38 weeks is often advocated to lessen that risk</li>
                                        </ul>
                                    </p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Renal disease</strong>:
                                        <ul style="margin-top: 0.5rem; margin-bottom: 0; color: white;">
                                            <li>Moderate-severe chronic renal disease usually worsens during pregnancy and may not improve after delivery</li>
                                            <li>Renal disease causes increased rates of intrauterine growth restriction, preterm delivery and perinatal loss</li>
                                            <li>Multidisciplinary management is necessary to optimize the outcome for woman and fetus</li>
                                        </ul>
                                    </p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Thyroid disease</strong>:
                                        <ul style="margin-top: 0.5rem; margin-bottom: 0; color: white;">
                                            <li>Hypothyroidism is most commonly due to autoimmune disease or iatrogenic (post-thyroidectomy). Iodine deficiency is less common. Raised levels of TSH are diagnostic, and the effectiveness of thyroxine treatment should be monitored with TSH levels</li>
                                            <li>Hyperthyroidism in pregnancy is usually due to Graves' disease. It can cause low birth weight, and premature labour and birth. Treatment is with anti-thyroid drugs</li>
                                        </ul>
                                    </p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Obesity</strong>:
                                        <ul style="margin-top: 0.5rem; margin-bottom: 0; color: white;">
                                            <li>Ideally obese women should defer pregnancy until they reach their optimal BMI.</li>
                                            <li>Obese women should have hospital-based care because of the increased risks</li>
                                            <li>Screening should be undertaken for gestational diabetes and excessive fetal growth</li>
                                            <li>Special preparation is necessary for a caesarean section (e.g., a large operating table)</li>
                                        </ul>
                                    </p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Epilepsy</strong>:
                                        <ul style="margin-top: 0.5rem; margin-bottom: 0; color: white;">
                                            <li>A minority of women have an increase in fit frequency in pregnancy</li>
                                            <li>All anti-epileptic drugs have been reported to be teratogenic, with sodium valproate appearing to have the greatest risk. However, the hazards of epilepsy exceed risks of treatment</li>
                                            <li>The main priority in pregnancy is to prevent seizures with the fewest drugs and at the lowest dose</li>
                                        </ul>
                                    </p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Cardiac disease</strong>:
                                        <ul style="margin-top: 0.5rem; margin-bottom: 0; color: white;">
                                            <li>The risks for the woman and fetus vary with the diagnosis</li>
                                            <li>The NYHA classification gives an indication to the severity of the cardiac disease in the woman, though some of the symptoms of cardiac disease are also normal physiological complaints in pregnancy</li>
                                            <li>Surveillance and management should be by a multidisciplinary team and individualized</li>
                                        </ul>
                                    </p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Respiratory disease</strong>:
                                        <ul style="margin-top: 0.5rem; margin-bottom: 0; color: white;">
                                            <li>Asthma: This is common in pregnancy and is not commonly exacerbated by the pregnancy; Some symptoms are normal complaints in pregnancy; Baseline peak flow measurements should be taken at the start of pregnancy; Treatment for both acute attacks and ongoing maintenance is the same as for non-pregnant individuals and is considered safe</li>
                                            <li>Cystic fibrosis: Though an uncommon condition it associated with increased risk for woman and fetus; Surveillance and management should be by a multidisciplinary team and individualized</li>
                                        </ul>
                                    </p>
                                </li>
                            </ul>
                        </div>
                    </aside>
                </div>

                <!-- Bottom Navigation -->
                <nav class="document-nav document-nav--bottom" role="navigation" aria-label="Document navigation">
                    <div class="nav-container">
                        <a href="chapter-08-obstetric-disorders.html" class="nav-button nav-button--prev nav-button--large">
                            <span class="nav-icon">‚Üê</span>
                            <div class="nav-content">
                                <span class="nav-label">Previous</span>
                                <span class="nav-title">Obstetric Disorders</span>
                            </div>
                        </a>
                        
                        <a href="../index.html" class="nav-button nav-button--toc">
                            <span class="nav-icon">üìö</span>
                            <span class="nav-text">All Topics</span>
                        </a>
                        
                        <a href="chapter-10-fetal-wellbeing.html" class="nav-button nav-button--next nav-button--large">
                            <div class="nav-content">
                                <span class="nav-label">Next</span>
                                <span class="nav-title">Congenital Abnormalities & Fetal Wellbeing</span>
                            </div>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <!-- Lightbox Modal -->
    <div class="lightbox-modal" id="lightbox-modal" role="dialog" aria-modal="true" aria-label="Image viewer" hidden>
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <!-- Scripts -->
    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>